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CHAPTER I 
 
GENERAL INTRODUCTION 
 
Since more than a thousand years ago, humankind have been making alcohol beverages, miso 
and soy source by means of microbial fermentation. In modern times, additionally many kinds 
of biochemicals (amino acids, antibiotics, enzymes, vaccines et al.) have been made with 
microorganisms and the biochemicals have become greatly essential in our society. In Japan, 
from sixties to seventies of the last century, a lot of useful antibiotics were discovered and 
technologies required for industrial production of amino acids and nucleic acids had been 
extensively developed. The core technology of the industry is fermentation by using microbes of 
which metabolic pathways were engineered by conventional mutations with UV irradiation and 
chemical mutagens. 
Recently, not only developed countries such as U.S.A. and Germany but also Asian countries 
such as Korea and China have become competitive in the fermentation industry. Under such 
circumstances, it is indeed necessary for Japanese fermentation industry to improve their 
productivities extensively from the novel standpoints of microbiology and biochemistry. 
Although Japanese fermentation industry had spent many years for finding new catabolic 
pathways and making the pathways stronger or more highly active by using mutations and 
genetic engineering, the intracellular metabolic pathways have not been rate-limiting steps 
anymore and the productivities of fermented biochemicals have reached plateaus. Therefore, 
completely new strategies are required for a breakthrough in the improvement of productivities. 
Then, I paid attention to the two processes of solute transport across plasma membranes such 
as import of substrates into cells and export of metabolic end-products from cells because 
transport processes of solutes across plasma membranes have been the rate-limiting steps in the 
modern fermentation industry. In microorganisms, transport processes of materials across 
membranes are strictly regulated to maintain their homeostasis, and the regulation prevents both 
import of unnecessary solutes and export of metabolites required for cells. From the above 
reasons, I suggest that it is necessary to control the transport processes artificially for extensive 
improvement of productivities of biochemicals. 
Amino acid transport systems are ubiquitously found in eukaryotes and prokaryotes. Besides their 
role in the uptake of amino acids required for catabolism or protein synthesis, in eukaryotes these 
carriers are also involved in functions such as signal transduction processes in the nervous system. 
The physiological advantage of the presence of amino acid uptake systems for bacterial cells is 
obvious. On the one hand, externally available amino acids can be used directly for protein synthesis 
without spending energy for anabolism, and they can, on the other hand, be catabolized, serving as 
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carbon, energy and/or nitrogen source. While amino acid uptake is obviously beneficial for the cell, 
the physiological significance of amino acid excretion in microorganisms is less obvious. From the 
view that amino acid efflux in industrial processes is too complex, studies of specific mechanisms 
for amino acid excretion with mutant strains of Escherichia coli and Corynebacterium glutamicum, 
are originally prevented investigations. However, Kramer and coworkers succeeded in 
demonstrating that the excretion of L-threonine from E. coli and the excretion of L-glutamate, 
L-lysine, L-isoleucine, and L-threonine from C. glutamicum are active transport processes (1). Based 
on these seminal studies, it has recently become possible to identify specific export carriers at the 
molecular level. This has led to the identification of novel transporter families and to basic insights 
into the bacterial amino acid balance (Table 1). 
 
 
Industrial Applications and Production of Amino Acids 
 
In 1908 L-glutamate was identified as the flavor-enhancing compound of seaweed and soy 
sauce used in traditional Japanese cuisine (2). The breakthrough of biotechnological 
L-glutamate production came with the discovery of a bacterium able to produce considerable 
amounts of this amino acid. In 1957, Kinoshita and co-workers isolated C. glutamicum, at that 
time designated Micrococcus glutamicus, based on its ability to excrete L-glutamate (3).  
Currently, C. glutamicum plays a dominant role in the production of amino acids, followed by E. 
coli. 
Amino acids are used for a wide variety of purposes. Three main applications can be 
distinguished: food, feed, and pharmaceuticals. The economic value of produced amino acids 
reached more than US$ 3 billion in 1998 and this market is growing steadily by 5–10% per year. 
In the food sector, more than 1,500,000 tons of L-glutamate are used per year as a flavor 
enhancer in Asian cuisine, different spices, sauces, and in ready-to-eat meals, typically in 
concentrations between 0.1 and 0.4%. The reason for this surprisingly high demand is the fact 
that the taste of sodium glutamate is pleasant for most people. Besides sweet, sour, salty, and 
bitter, humans have also a special sense for L-glutamate, designated umami. The corresponding 
receptor was identified recently (4). Most likely, umami has the physiological function to 
indicate proteinaceous high quality food. Other examples for the application of amino acids in 
food are L-aspartate and L-phenylalanine, produced in amounts of approximately 15,000 tons 
per year and used for the production of sweeteners (Aspartame), and glycine, which is added to 
sweeteners to mask the aftertaste of saccharin. The dominant amino acid used for supplementing 
feed for cattle, pigs, or poultry is L-lysine, with a current annual production of approximately 
70,000 tons. In the past two decades the world market for this amino acid has increased more 
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than 20-fold (5). In addition, D, L-methionine (350,000 tons per year) and L-threonine (15,000 
tons per year) are also added to the animal diet. The pharmaceutical industry requires L-amino 
acids mainly for infusion solutions. Some amino acids are also used directly as therapeutics, e.g. 
L-tryptophan, which is a sleep inducer, or L-phenylalanine, prescribed as an antidepressive. 
Amino acids are furthermore used as building blocks in the synthesis of different therapeutics. 
Based on the historical development of amino acid production, the Asian, especially Japanese, 
fermentation industry has dominated the amino acid market for a long time. Today Japanese 
companies such as Ajinomoto and Kyowa Hakko are important in this field, as well as the 
Korean company Cheiljedang. However, nowadays the Asian amino acid producers are being 
challenged by companies from the USA (Archer Daniels Midland, ADM) or from Germany 
(Degussa and BASF). This strong competition has resulted in low product prices; consequently, 
for cost reasons, production plants have often been located near the market of their product. The 
supply of raw material, i. e. molasses, starch liquor, or sucrose, is another cost factor influencing 
the location of production sites. While L-glutamate production facilities are spread all over the 
world, with a strong presence in Asia, e.g. in China, Indonesia, and Thailand, one third of the 
L-lysine production capacity is concentrated in the USA, because of the local importance of 
meat production. 
 
 
Lactic Acid Bacteria (LAB) 
 
LABs are fermentative organisms which obtain their metabolic energy (energy which can be 
used for energy-requiring processes in the cell) mainly by substrate level phosphorylation. 
LABs have a relatively simple metabolism and make high demands on the nutritional 
composition of their growth media. Usually, in addition to carbon and energy sources, various 
amino acids, vitamins, nucleic acids and mineral components are required. The environments in 
which LABs thrive are restricted by these requirements and are often associated with plants, 
meat and dairy products (6). The genome sizes of LABs are relatively small, which is consistent 
with their simple metabolic capabilities. The genome of Lactococcus lactis IL1403 contains 
2,365,589 base pairs and encodes 2,310 proteins (Bolotin, Wincker et al. 2001). This is about 
half the size of the genome of E.coli. The importance of the cytoplasmic membrane for growth 
and survival of L.lactis is evident from the observation that about 17% of all proteins encoded 
by its genome are involved in biosynthesis and function of the cytoplasmic membrane (7). The 
metabolic energy supplied by fermentation is small. In the metabolism of glucose to lactate, two 
ATP are formed while an additional ATP can be obtained in further metabolism of pyruvate to 
acetate. This ATP is needed for the synthesis of cellular macromolecules and other energy 
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requiring processes in the cytoplasm and in the cytoplasmic membrane and for the generation 
and maintenance of a proton motive force (pmf) by the membrane bound F0F1-ATPase (8). The 
supply of metabolic energy by fermentation is usually not sufficient to allow maximum rates of 
the biosynthetic machinery and this restricts the growth rate and the growth yield of LABs. 
Moreover, in their natural habitats LABs encounter drastic fluctuations in the composition of 
their environment. Consequently, LABs are often in a transient state with periods of abundant 
supply of energy followed by periods of starvation. When the energy source runs out the rate of 
glycolysis rapidly decreases. This loss of glycolysis activity results in a diminished rate of ATP 
synthesis and consequently of pmf generation. It also results in a decreased supply of metabolic 
energy for vital cellular processes and this directly affects viability. If the energy supply is 
restored within a short period of time, glycolysis can start again and the internal ATP-pool and 
the pmf can be regenerated (9-11). L.lactis can survive periods of starvation for a few hours up 
to a few days, depending on the starvation media (12) and the growth conditions preceding the 
starvation phase (13). From the considerations presented above, it is evident that both during 
fermentation and transient states the LABs could benefit considerably from additional sources 
of usable metabolic energy, and such sources will directly contribute to growth and survival of 
the LABs. This additional energy is supplied by a variety of secondary transport systems. 
 
 
Metabolic Energy from Secondary Transport 
 
In order to grow and multiply, bacteria have to take up and often to accumulate a variety of 
solutes. Transport processes are energetically expensive and consume a large fraction of the 
metabolic energy supply. The metabolic energy cost of transport of a solute by an ABC 
transporter is at least one ATP per transport event (14). Secondary transporters are usually 
energetically less expensive than ABC-transporters. Since the synthesis of one ATP by the 
F0F1-ATPase requires the influx of 3–4 protons (15), the metabolic energy requirement of 
symport of a neutral solute with one proton represents 1/3 to 1/4 ATP equivalents. Growth 
requires not only the uptake of solutes (precursors) but also the excretion of the end products of 
metabolism. Since end products are produced inside the cell and excreted to the environment, 
these excretion processes usually occur down the end product concentration gradients. This 
suggests that the end product concentration gradient might contain enough energy to drive its 
own transport out of the cell. If the excretion of end products occurs via secondary transport 
systems in symport with protons and/or charges, this excretion can lead to the generation of a 
pmf. A variety of transport processes have indeed been found to generate instead of consume a 
pmf and to supply additional metabolic energy. These mechanisms for metabolic energy 
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generation are especially found in organisms that live under energy-limited conditions such as 
LABs. The metabolic energy generating transport systems found so far in several bacteria all 
belong to the secondary transporters and include uniporters, proton-solute symporters and 
antiporters (16,17) (Table 2). The driving forces for solute transport across the cytoplasmic 
membrane by secondary transport systems are supplied by the electrochemical gradients of the 
solutes and ions that are translocated in a coupled process. For every net positive charge that is 
translocated from outside to inside (or every net negative charge from in to out) the electrical 
potential  contributes once to the driving force; for every proton translocated from out to in, 
the transmembrane pH-gradient pH (= – log[H+]in/log[H+]out) is a driving force and for 
every solute and product translocated the chemical gradient of solute S (=  log [S]in/[S]out) 
and of product P (=  log[P]out/ [P]in) are driving forces of the translocation process (18). All 
these forces are expressed in mV. When the sum of these forces has a negative value solute will 
be driven from outside to inside and products from inside to outside. When protons are taken up, 
the pH will decrease while the  will decrease when net positive charges are taken up or net 
negative charges are exported. Secondary transporters can translocate solutes in both directions 
and the direction depends only on the direction of the driving force of the transport process. 
When transport results in the translocation of protons and positive charges from in to out, a pH 
and  and thus a pmf will be generated. A special mechanism of pmf generation occurs when 
positive charges are taken up or negative charges extruded in the transport process while protons 
are not translocated but consumed internally during solute metabolism in the cytoplasm. This 
proton consumption will lead to alkalinization of the cytoplasm and the generation of a pH, 
inside alkaline. The transport process together with metabolism then will lead to the generation 
of a pmf (18). 
 
 
Electrogenic Exchange 
 
Additional metabolic energy in the form  can be gained when the exchange process is 
electrogenic i.e. when net charge is translocated in the exchange process, while proton 
consumption during metabolism can result in the formation of a pH. When, during 
fermentation, solutes are taken up from the external medium via specific secondary transporters 
in exchange for products with a different charge than the solute and obtained by internal 
metabolism of the solute. Examples of such electrogenic exchange processes are found in a 
number of the decarboxylation processes (Table 2; (17,19-23)). In these decarboxylation 
processes the other component of the pmf, the transmembrane pH gradient. –pH, is formed 
during the decarboxylation of the precursor. In this enzymatic reaction protons are taken up 
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from the cytoplasm resulting in an increase of the cytoplasmic pH and consequently the 
generation of a transmembrane pH gradient. Thus, by compartimentalization of the 
decarboxylation pathway, the free energy of the decarboxylation reaction can be converted into 
a pmf. An interesting feature of these decarboxylation processes is that their sole purpose 
(except for citrate fermentation) is to supply the cells with metabolic energy and that none of the 
components of the precursors serve other metabolic functions. In this respect the precursors 
have similar functions for the cells as gasoline has for a car. Several LABs carry out malolactic 
fermentation (24). Kramer and coworkers have seen above that at low pH as in O. oenis 
malolactic fermentation involves an electrogenic uniport step coupled to a proton consuming 
decarboxylation step. The process in LABs that grow at higher pH values is different since 
above pH 6 malate is mainly present as Malate 
2–
. For example, during malolactic fermentation 
by L. lactis this Malate 
2–
 is taken up and subsequently decarboxylated by malolactic enzyme to 
yield lactate. Again, due to the higher internal pH, lactate is mainly present as Lactate
–
 and 
leaves the cell via the malate transporter. In L. lactis, Malate
2–
/ Lactate
–
 exchange is therefore an 
electrogenic process in which negative charge is translocated from outside to inside and a proton 
is consumed in the decarboxylation process. As in O. oeni, malolactic fermentation thus results 
in the generation of both components of the pmf. In L. lactis, this process can generate a pmf of 
sufficiently high value to drive ATP synthesis via the F0F1-ATPase (20). An additional 
beneficial effect of malolactic fermentation is the external replacement of malate by lactate. Due 
to the pK difference of the carboxylic acid groups of malate and lactate, this conversion results 
in the alkalinization of the medium. Several LABs perform amino acid decarboxylation at the 
end of food fermentation, when their carbon and energy sources have been consumed. These 
decarboxylations lead to the production of biogenic amines such as histamine, cadaverine, 
putrescine, tyramine and tryptamine (25-27). These biogenic amines are very toxic for humans 
and are responsible for some serious cases of food poisoning. An example is the 
decarboxylation of Histidine to the biogenic amine histamine by Lactobacillus buchneri (28). 
The pKs of the imidazol ring of histidine and histamine are 6.0 and 5.8, respectively, and the 
protonation state of the side chain of both molecules will have a similar pH dependency. At the 
medium pH of 7 Histidine enters the cell in the monocationic form, while the same transporter 
excretes histamine with two positive charges due to the higher internal pH. This makes the 
histidine/histamine exchange process electrogenic, resulting in the net movement of a positive 
charge to the outside and the generation of a , inside negative. Additionally, a pH is formed 
by the decarboxylation reaction as described above. These amino acid decarboxylation 
processes are crucial for several LABs to survive periods of energy starvation. As early as 1924 
it was suggested that these processes also might fulfill a protective function against intracellular 
and extracellular acidification (29-31). Another metabolic energy generating decarboxylation 
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process is found in citrate fermentation in several LABs. Citrate fermentation coupled pmf 
generation in LABs involves more complex metabolic processes and consists of a number of 
metabolic steps, as has been reviewed in Konings (18) Citrate metabolism in Leuconostoc 
mesenteroides, O. oeni and L. lactis have been shown to lead to the generation of a pmf 
(22,32,33). In O. oeni, citrate and malolactic fermentations have important functions as 
precursors of aroma compounds in wine production (e.g. acetoin and diacetyl) (24). Also in 
milk fermentation, citrate metabolism contributes to flavor production (diacetyl and acetoin) 
(34). In addition to its contribution to the energy status of the cells, citrate metabolism in LABs 
can have a number of other important physiological consequences such as relieving acid stress 
by alkalinizing the cytoplasm and eventually the medium.  
 
 
Aspartate:Alanine Exchange of Lactic Acid Bacterium 
 
The gram-positive lactic acid bacterium Tetragenococcus halophilus is used to ferment soy sauce, 
which contains large amounts of amino acids, including L-aspartate (aspartate), sugars, such as 
hexoses and pentoses, and sodium chloride (ca. 17%) (35). Some strains of T. halophilus 
catalyze decarboxylation of aspartate with nearly stoichiometric release of L-alanine (alanine) and 
CO2 (35,36). Based on analogy to our previous work on Lactobacillus subspecies M3 (37), 
aspartate decarboxylation is thought to be advantageous for tetragenococcal cells because 
aspartate consumption concomitant with release of alanine generates rather than consumes metabolic 
energy and regulates the intracellular pH. The net charge movement during the exchange of aspartate 
with alanine results in a membrane potential of physiological polarity (Fig. 1). Furthermore, 
decarboxylation reactions consume scalar protons and thus generate a pH gradient of physiological 
polarity. The combined activities of the precursor-product exchange and decarboxylation result in a 
proton motive force that is sufficiently high to drive ATP synthesis via FoF1 ATPase (Fig. 1). Such 
metabolic systems are proposed as proton motive metabolic cycles, and the prototype model is found 
in the oxalate-formate exchange system of Oxalobacter formigenes (19,21,38). In one strain, T. 
halophilus D10, Abe et al. found a 25-kb plasmid responsible for the trait of L-aspartate 
decarboxylation; they cloned and sequenced the asp operon, which consists of two genes designated 
aspD and aspT. aspD encodes an L-aspartate 4-decarboxylase (AspD), and aspT an aspartate: 
alanine antiporter (AspT) (39). In addition, they demonstrated the electrogenic character of the 
aspartate-alanine exchange catalyzed by AspT by means of proteoliposomes. The AspT originally 
served to characterize the aspartate:alanine exchanger (AAE) family of secondary transporters 
(Saier et al., http://www.tcdb.org/). AAE family transporter has many bacterial homologues of 
unknown function and one very distant homologue in the archaeon, Halobacterium sp. strain 
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NRC-1. This last protein (384 aas; 10–12 putative TMSs; AAC82885) is the only AAE family 
member from an archaeon in the NCBI database, and there are none from eukaryotes. Each of 
the two hydrophobic halves of AAE family proteins contains six peaks of hydropathy that may 
correspond to 5 or 6 TMSs. Table 3 presents the members of the AAE family in alphabetical 
order according to species name. These proteins are almost all large, between 516 and 580 
residues (40). 
This aspartate:alanine exchange systems (Fig. 1) have the following favorable natures for 
energy supply in industrial fermentation; (i) small and compact (Mw and number of genes), (ii) 
closed (no interference by other reactions), (iii) irreversible reaction, (iv) energy productive. 
This system has already been applied in soy sauce fermentation and the annual production 
volume of soy sauce using the system reaches approximately 400,000 tons. From the above 
backgrounds, I chose this reaction as a model solute transport system for highly efficient 
biochemical production. In this thesis, I studied the structure and transport mechanisms of 
aspartate:alanine antiporter (AspT) as a fundamental research for highly efficient biochemical 
production. 
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Table1 Genes and transporters related to amino acid production in Corynebacterium glutamicum and Escherichia coli: uptake and excretion systems
Species
Corynebacterium
glutamicum
Escherichia coli
Transporter
AroP
BrnQ
GluABCD
Glutamate permease
LysE
LysI
ThrE
AroP
Aspartate/glutamate
carrier
GltP
GltS
Glutamate excretion
carrier
LIV1
Orf299
PheP
RhtA
RhtB
RhtC
SstT
TdcC
Threonine permease
Gene(s)
aroP
brnQ
gluABC
D
?
lysE
lysI
thrE
aroP
?
gltP
gltS
?
livGHJM
ydeD
pheP
rhtA
rhtB
rhtC
sstT
tdcC
?
Substrate(s)
L-Trp, L-Tyr, L-Phe
L-Ile
L-Glu
L-Glu
L-Lys, L-Arg
L-Lys, L-Ala, L-Val, L-Leu
L-Thr, L-Ser
L-Trp, L-Tyr, L-Phe
L-Asp, L-Glu
L-Asp, L-Glu
L-Glu
L-Glu
L-Leu, L-Ile, L-Val, L-Ala,
L-Thr, L-Hom
L-Cys and components of
the cysteine pathway
L-Phe
L-Ser, L-Thr
L-Leu, L-Ser, L-Thr, L-
L-Thr, L-Ser
Characteristics
Aromatic amino acids uptake system
Na+-coupled uptake system
Binding protein-dependent uptake system,
expression glucose-repressed
Uptake active in complex medium
Exporter, expression regulated by LysG,
coinducers L-citrulline and L-histidine
Low capacity antiporter
Export carrier
General uptake system for aromatic amino
Binding protein-dependent uptake system,
inhibited by cysteate
Na+-independent uptake, inhibited by cysteate
and hydroxyaspartate
Na+-dependent uptake, inhibited by
methylglutamate
Stringent response-related export
Binding-protein-dependent uptake system,
expression repressed by LRP
Major facilitator protein involved in efflux
High-affinity uptake system specific for
phenylalanine
Na+-coupled serine/threonine importer
Importer active under anaerobic conditions
Na+-independent uptake system
Confer resistance to high concentrations of
homoserine and threonine, putative threonine
excretion carriers
Reference(s)
W ehrmann et al. 1995
T auch et al. 1998
Kronemeyer et al. 1995
Burkovski et al. 1996
V rljic et al. 1996 ; Bellmann et
al. 2001
Seep-Feldhaus et al. 1991
Simic et al. 2001
Brown 1970
Schellenberg and Furlong 1977
Deguchi et al. 1989 ; Wallace et
al. 1990 ; Tolner et al. 1992
Deguchi et al. 1990 ; Kalman et
al. 1991
Broda 1968 ; Burkovski et al.
1995
T empleton and Savageau 1974
Das ler et al. 2000
Pi et al. 1999
Zakataeva et al. 1997
Aleshin et al. 1999 ; Zakataeva
et al. 1999
Ogawa et al. 1998
Sumantran et al. 1990
Kruse et al. 2001
A.Burkovski & R. Kramer, Appl. Microbiol. Biotechnol. (2002) 58:265-274
Table 2 Metabolic energy supplying solute transport systems in bacteria
Systems
Malate influx
Citrate influx
Lactate efflux
Arginine/Ornithine
Lactose/Galactose
Oxalate/Formate
Malate/Lactate
Lysine/Cadaverine
Glutamate/GABA
Histidine/Histamine
Phenylalanine/Phenylethyl Amine
Tyrosine/Tyramine
Aspartate/Alanine
Citrate/Lactate
Arginine/Agmatine
Organism
O. oeni
O. oeni
L. lactis
L. lactis
S. thermophilus
O. formigenes
L. lactis
Lb. plantarum
E. coli
Lactobacillus ssp.
Lb. buchneri
Lb. buchneri
Lb. buchneri
Lb. ssp.M3
Lc .mesenteroides
L. lactis
E. coli
References
Salema et al. (1994)
Ramos et al.(1994)
Michels et al. (1979)
Driessen et al. (1987d)
V eenhoff et al. (2001)
Anantharam et al. (1989)
Poolman et al. (1991)
Meng and Bennet (1992)
Higuchi et al. (1993)
Molenaar et al.(1993)
Konings et al. (1995)
Konings et al. (1995)
Abe et al. (1996)
Marty-Teysset et al. (1996)
Bandell et al. (1998)
Gong et al. (2003)
Uniport
Proton-product symport
Electroneutral exchange
Electrogenic exchange
Wil N. Konings, Antonie van Leeuwenhoek (2006) 90:325-342
T able 3 Homologs of the AAE family.
Cluster #
1
2
3
4
5
6
7
8
9
10
11
12
Name
Eca1
Ppr1
Sen1
Sfl1
Vch1
Vfi1
Vpa1
Vvu1
Y ps1
Bbr2
Dps2
Vfi2
Bja3
Bfu1
Bfu2
Ftu1
Pda1
Reu1
Reu2
Rme2
Zmo1
Lac1
Tha1
Bfr2
Bth1
Bbr1
Bja1
Bja2
Rme1
Son1
Bfr5
Bfr7
Bfr3
Bth2
Bth4
Pgi1
Pgi2
Apl1
Eca2
Eco4
Hin1
Hso1
Msu2
Msu1
Pmu1
Ppr3
Sen4
Y ps2
Bfr9
Bth3
Dps1
Cau1
Cdi1
Cdi2
Cef2
Cef1
Cgl2
Cgl1
Gme1
Gsu1
Pac1
Reu3
Sth1
Rba1
Fnu1
Hsp1
Species
Erwinia carotovora subsp. atroseptica SCRI1043
Photobacterium profundum
Salmonella enterica subsp. enterica serovar Choleraesuis str. SC-B67
Shigella flexneri 2a str. 301
Vibrio cholerae O1 biovar eltor str. N16961
Vibrio fischeri ES114
Vibrio parahaemolyticus RIMD 2210633
Vibrio vulnificus YJ016
Y ersinia pseudotuberculosis IP 32953
Bordetella bronchiseptica RB50
Desulfotalea psychrophila LSv54
Vibrio fischeri ES114
Bradyrhizobium japonicum USDA 110
Burkholderia fungorum LB400
Burkholderia fungorum LB400
Francisella tularensis subsp. tularensis SCHU S4
Pseudomonas dacunhae ATCC 21192
Ralstonia eutropha JMP134
Ralstonia eutropha JMP134
Ralstonia metallidurans CH34
Zymomonas
mobilis
Lactobacillus acidophilus NCFM
Tetragenococcus halophilus
Bacteroides fragilis YCH46
Bacteroides thetaiotaomicron VPI-5482
Bordetella bronchiseptica RB50
Bradyrhizobium japonicum USDA 110
Bradyrhizobium japonicum USDA 110
Ralstonia metallidurans CH34
Shewanella oneidensis MR-1
Bacteroides fragilis NCTC 9343
Bacteroides fragilis NCTC 9343
Bacteroides fragilis YCH46
Bacteroides thetaiotaomicron VPI-5482
Bacteroides thetaiotaomicron VPI-5482
Porphyromonas gingivalis W83
Porphyromonas gingivalis W83
Actinobacillus pleuropneumoniae serovar 1 str. 4074
Erwinia carotovora subsp. atroseptica SCRI1043
Escherichia coli CFT073
Haemophilus influenzae R2866
Haemophilus somnus 2336
Mannheimia succiniciproducens MBEL55E
Mannheimia succiniciproducens MBEL55E
Pasteurella multocida subsp. multocida str. Pm70
Photobacterium profundum SS9
Salmonella enterica subsp. enterica serovar Typhi Ty2
Y ersinia pseudotuberculosis IP 32953
Bacteroides fragilis YCH46
Bacteroides thetaiotaomicron VPI-5482
Desulfotalea psychrophila LSv54
Chloroflexus aurantiacus
Corynebacterium diphtheriae NCTC 13129
Corynebacterium diphtheriae NCTC 13129
Corynebacterium efficiens YS-314
Corynebacterium efficiens YS-314
Corynebacterium glutamicum ATCC 13032
Corynebacterium glutamicum ATCC 13032
Geobacter metallireducens GS-15
Geobacter sulfurreducens PCA
Propionibacterium acnes KPA171202
Ralstonia eutropha JMP134
Symbiobacterium thermophilum IAM 14863
Rhodopirellula baltica SH 1
Fusobacterium nucleatum subsp. nucleatum ATCC 25586
Halobacterium sp. NRC-1
T ype of Bacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
b-Proteobacteria
d-Proteobacteria
g-Proteobacteria
a-Proteobacteria
b-Proteobacteria
b-Proteobacteria
g-Proteobacteria
b-Proteobacteria
b-Proteobacteria
b-Proteobacteria
b-Proteobacteria
a-Proteobacteria
Firmicutes
Firmicutes
Bacteroidetes
Bacteroidetes
b-Proteobacteria
a-Proteobacteria
a-Proteobacteria
b-Proteobacteria
g-Proteobacteria
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
g-Proteobacteria
Bacteroidetes
Bacteroidetes
d-Proteobacteria
Chloroflexi
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
d-Proteobacteria
d-Proteobacteria
Actinobacteria
b-Proteobacteria
Actinobacteria
Planctomycetacia
Fusobacteria
Halobacteria
Size
562
560
561
561
558
560
560
580
562
565
669
625
562
560
560
571
561
561
564
557
564
552
543
565
564
571
567
516
561
562
562
553
554
554
555
561
558
552
552
561
551
552
297
280
553
552
553
552
532
532
541
544
561
541
530
542
533
539
546
546
525
532
542
534
468
384
Ravi D. Barabote et al, Biochemical Biophysica Acta (2006) 1557-1579
AspT
Asp-1
Asp-1 Ala0
Ala0
AspD
H+ CO2
+ + + +
----
∆ψ & ∆ H+
ATPADP
3H+
F1Fo-ATPase
Fig. 1 A proton-motive metabolic cycle associated with aspartate decarboxylation. The
diagram describes decarboxylative phosphorylation in Lactobacillus subspecies M3 and T.
halophilus. As outlined in the text, a proton motive force is established by the combined
activity of the vectorial AspT antiport reaction and the scalar internal aspartate
decarboxylation. Entry of monovalent aspartate in exchange for nonvalent alanine generates
an electrical potential, negative inside; consumption of a proton during decarboxylation
generates an internal alkalinity. Three antiport cycles provide sufficient energy for the
synthesis of one ATP.
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CHAPTER II 
 
 
 
Membrane Topology of the Electrogenic Aspartate-Alanine Antiporter AspT of 
Tetragenococcus halophilus. (Determined by Fusion Methods) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter was published in: 
Biochem. Biophys. Res. Commun. (2005), 328:20-26.  
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CHAPTER II 
 
ABSTRACT  
AspT is an electrogenic aspartate: alanine exchange protein that represents the vectorial 
component of a proton-motive metabolic cycle found in some strains of Tetragenococcus 
halophilus. AspT is the sole member of a new family, the Aspartate: Alanine Exchanger (AAE) 
Family, in secondary transporters, according to the computational classification proposed by 
Saier et al. (http://www.biology.ucsd.edu/~msaier/transport/). We analyzed topology of AspT 
biochemically, by using fusion methods in combination with alkaline phosphatase (PhoA) or 
-lactamase (BlaM). These results suggested that AspT has a unique topology; 8 TMS, a large 
cytoplasmic loop (183 amino acids) between TMS5 and TMS6, and N and C-termini that both 
face the periplasm. These results demonstrated a unique 2D-structure of AspT as the novel AAE 
family. 
 
 
INTRODUCTION 
Some strains of Tetragenococcus halophilus (previously called T. halophila) catalyze 
decarboxylation of L-aspartate with near-stoichiometric release of L-alanine and CO2 [1, 2] . 
L-aspartate decarboxylation is thought to be advantageous to the bacterial cells, because 
L-aspartate consumption concomitant with release of L-alanine generates, rather than consumes, 
metabolic energy and regulates the intracellular pH [3, 4] . The net charge movement during the 
exchange of L-aspartate with L-alanine results in a membrane potential of physiological polarity. 
Furthermore, decarboxylation reactions consume scalar protons and thus generate a pH gradient 
of physiological polarity. The combined activities of the precursor–product exchange and 
decarboxylation result in a proton-motive force (PMF) that is sufficiently high to drive ATP 
synthesis via the bacterial F0F1 ATPase. Such metabolic systems are proposed as a 
proton-motive metabolic cycle, and the prototype model is found in Oxalobacter formigenes [3, 
5, 6] . Over the past 10 years, a number of presumed proton motive metabolic decarboxylation 
cycles have been identified in several bacterial species, including glutamate to -aminobutyrate 
[7-9] , malate to lactate [10] , and histidine to histamine [11] . 
In one strain, T. halophilus D10, we previously found a 25-kb plasmid responsible for the trait 
of L-aspartate decarboxylation [1] and cloned and sequenced the asp operon, which consists of 
two genes that we designated aspD and aspT. aspD encodes an L-aspartate -decarboxylase 
(AspD), and aspT an aspartate: alanine antiporter (AspT)[4] . The two genes were successfully 
expressed in Escherichia coli. We solubilized AspT from membranes of the E. coli cells and 
demonstrated the electrogenic character of the aspartate: alanine exchange catalyzed by AspT 
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using proteoliposomes [4] . 
Analysis of the amino acid sequence of AspT revealed it to be a hydrophobic membrane 
protein. The biochemical features of AspT transport demonstrated by using proteoliposomes 
indicated that AspT should be classified as a conventional secondary transport protein, as an 
electrogenic antiporter similar to the prototype of precursor–product exchanger OxlT from O. 
formigenes [3, 5, 6, 12, 13] . However, AspT had low sequence similarities (< 20%) of amino 
acids to known membrane transporters, including PMF-generating antiporters [3, 8, 14] , 
suggesting that the structures of PMF generating antiporters are divergent. At this time, T. 
halophilus AspT is the sole transporter that has been biochemically shown to be an electrogenic 
aspartate: alanine exchanger, and it is the sole member of a family of secondary transporters 
called Aspartate: Alanine Exchanger (AAE) according to the classification proposed by Saier 
(http://www.biology.ucsd.edu/~msaier/transport/). However, the secondary structure of AspT 
has remained unclear. Prediction of the AspT membrane topology from hydropathy profiles by 
using several prediction programs gave several different models having 9–12 transmembrane 
segments (TMS), and the segments having middle range of hydrophobicity were ambiguously 
predicted in the present study. The topology of cytoplasmic membrane proteins in bacteria has 
often been studied biochemically by using phoA and blaM gene-fusion methods [15-17] . Both 
alkaline phosphatase (PhoA) and -lactamase (BlaM) are enzymatically active after 
translocation to the periplasm, but are inactive when localized in the cytoplasm [15, 16] . 
Therefore, we biochemically analyzed the membrane topology of AspT by fusion methods, 
using PhoA and BlaM as reporter proteins.  
 
 
MATERIALS AND METHODS 
Bacterial strains and plasmids. The E. coli strains used were, first, LMG194 [F
-
 ara714 
leu::Tn10 lacX74 phoA (Pvu II) galE galK thirpsL] [18] , which was used for expression of 
the aspartate: alanine antiporter (AspT)–alkaline phosphatase (PhoA) fusion proteins by means 
of the pBADphoA plasmid. pBADphoA is a cloning vector containing a signal-sequenceless 
phoA with a Kpn I and a Nco I cloning site just upstream of phoA. The construction of 
pBADphoA from pSWFII [19] and pBAD22 [18] will be described elsewhere. Second, E. coli 
strain XL1 blue (recA1, endA1, gyrA96, thi, hsdR17, supE44, relA1, lac [F', proAB, lacI
q
ZM15, 
Tn10 (Tet
r
)]) harboring pMS421 (Spec
r
, LacI
q
) is here called strain XL3 [3] and was used for 
expression of the AspT–BlaM fusion proteins by means of the expression vector pYZ4 
containing Kan
r
 as a selection marker [20] . pKM1 is the mature -lactamase (BlaM) cassette 
plasmid, Tet
r
 [20] . 
Hydropathy analyses of AspT. The hydropathy profile of the T. halophilus AspT was 
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derived by the method of Eisenberg [21] using a sliding window of 15 amino acids (Fig. 1) 
Analysis of AspT-PhoA, AspT-BlaM fusion proteins. We biochemically investigated the 
two-dimensional membrane topology of AspT by using PhoA and BlaM fusion methods. The 
compartmental nature of PhoA and BlaM has been well established, and they are routinely used 
to investigate the topology of integral membrane proteins [22, 23] . Deletion derivatives of 
AspT were amplified from plasmid pBluescript II KS (+) including the aspTgene by PCR using 
primers that generated unique restriction sites at the 5' (Nco I) and 3' (Kpn I) ends. The 3' sites 
were designed to create in-frame fusions to the reporter cassettes upon ligation into either 
pBAD-PhoA (phoA) or pYZ4 (blaM). Such eighteen fusions were constructed and sequenced to 
verify the fusion junctions. Alkaline phosphatase specific activities of the AspT-PhoA chimeras 
were determined as described by Guan et al. [22] . The MICs of carbenicillin for strains 
expressing AspT-BlaM fusions were determined by spotting 5 μl of a 10-3 dilution of an 
overnight culture onto Luria-Bertani agar plates containing the antibiotic. The concentrations of 
carbenicillin ranged from 0 to 800 μg/ml. 
SDS-PAGE and western blotting Whole-cell lysates were prepared and subjected to 
polyacrylamide (10% or 12.5%) gel electrophoresis in the presence of SDS. After 
electrophoresis, the proteins were transferred to a polyvinylidene difluoride (PVDF) membrane 
(Nippon Genetics, Tokyo, Japan) by semidry electrophoretic blotting. PhoA and BlaM fusion 
proteins were detected with a PhoA detection kit (Bio-Rad Laboratories, Hercules, CA) 
according to the manufacturer’s instructions. Antisera were used at following dilutions: 
anti-bacterial alkaline phosphatase mouse monoclonal antibodies (Sigma Chemical, Tokyo, 
Japan), 1:7500; anti-mouse immunoglobulin G (heavy and light chains) horse polyclonal 
antibody PhoA-conjugate (Vector Laboratories, Burlingame, CA), 1:7500; anti-bacterial 
β-lactamase rabbit polyclonal antibodies (5′–3′, Boulder, CO), 1:1000; and anti-rabbit 
immunoglobulin G (heavy and light chains) goat polyclonal antibody PhoA-conjugate (Nacalai 
Tesque, Kyoto, Japan), 1:5000.  
 
 
RESULT AND DISCUSSION 
Hydropathy analyses of AspT. Despite the fact that the accumulating number of bacterial 
genome sequences reveals that AspT homologs may be present in several bacterial species, the 
structure of AspT remains unknown. The hydropathy profile of the T. halophilus AspT (Fig. 1) 
suggests that AspT is a polytopic membrane protein. Further analyses of AspT hydropathy by 
using the programs SOSui (http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0.html, [24] ), 
TMHMM (http://www.cbs.dtu.dk/services/TMHMM-2.0/, [25] , [26] ), and TMPred 
(http://www.ch.embnet.org/software/TMPRED_form.html, [27] ) predicted the presence of 9–12 
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transmembrane segments (TMS) in AspT, resulting in ambiguity and discrepancy of TMS 
predictions among the three models. 
Analysis of AspT-PhoA fusion proteins. We biochemically investigated the 
two-dimensional membrane topology of AspT by using PhoA and BlaM fusion methods. The 
locations of these fusions along with their enzymatic activities and subcellular locations are 
indicated in Table 1. Expression of the hybrid proteins derived from pBADphoA is under the 
control of the araBAD promoter; therefore, cells harboring the fusions were induced in the 
presence of 0.4% L-arabinose. To ascertain the proper expression of the hybrid proteins in the E. 
coli host (LMG194), cells were resuspended to 4 g protein/l in loading buffer and incubated 
for 12 h at 37C, after which 15 l samples were loaded onto sodium dodecyl sulfate 
(SDS)-polyacrylamide gels containing 10% polyacrylamide. After electrophoresis, the proteins 
were transferred to a poly vinylidene difluoride (PVDF) membrane (Nippon Genetics Co., Ltd., 
Tokyo, Japan) by semidry electrophoretic blotting, and visualized by immunoblotting using an 
antibody against PhoA (Fig. 2A). The mobility of most of the fusion proteins was within the 
range appropriate to their expected molecular mass. Some fusion proteins yielded extra bands 
having lower molecular mass than expected, suggesting proteolysis. In particular, more extra 
bands were observed for hybrid proteins in which the fusion junctions were likely to face the 
periplasmic side of the membrane (Cys
476
, Ser
543
). Expression levels of some fusion proteins 
were very low (Lys
87
, Ala
126
, Lue
151
, Ala
198
, Ser
448
, Ser
452
, Glu
506
), but we could confirm their 
expression by loading a larger amount of proteins (120 g) onto SDS-polyacrylamide gels (date 
not shown). Hybrid proteins with junction sites located after Gly
62
, Ala
126
, Leu
151
, Ser
386
, Lys
411
, 
Ser
448
, Ser
452
, Cys
476
 and Ser
543
 of AspT showed high alkaline phosphatase activities, indicating 
localization of these sites at or close to the periplasmic side of the membrane. The results for 
AspT–PhoA hybrid proteins fused at Ser543 indicate that the C-terminal amino acids of the 
corresponding AspT fragments are located at, or close to, the periplasmic side of the membrane. 
Low alkaline phosphatase activities were observed when the fusion sites were located after Ser
33
, 
Lys
87
, Ala
198
, Ala
273
, Glu
348
, and Glu
506
 of AspT. The PhoA–fusion analysis of AspT suggested 
that AspT has 8 TMS, and a large cytoplasmic loop (183 amino acids) located between TMS5 
and TMS6. Both the N and C-termini appear to face the periplasm.  
Analysis of AspT-BlaM fusion proteins. Since AspT–PhoA fusion analysis suggested the 
unique structural features of AspT as described above, we further examined the implications of 
the AspT–PhoA fusion results by using BlaM–AspT fusions for N-terminal analysis and 
AspT–BlaM fusions for analyzing other junction positions with the C-terminus of AspT. We 
designed two BlaM–AspT fusion genes; one expressed -lactamase lacking its signal sequence 
fused at its C-terminus with the full-length of AspT, and the other expressed the same protein 
fused with the N-terminal half of AspT. We also obtained 18 independent fusion genes 
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expressing a C-terminal deletion series of AspT fused with BlaM at the C-termini of the 
truncated AspTs. The expression of hybrid proteins derived from pYZ4 blaM–aspT or pYZ4 
aspT–blaM is under the control of the lacUV5 promoter; therefore, cells harboring the fusions 
were induced in the presence of IPTG. To examine proper expression of the hybrid proteins in 
the E. coli host (XL3), we ran SDS-PAGE of extracts prepared from whole cells harboring the 
plasmids and visualized the protein by immunoblotting using an antibody against BlaM. The 
results of Fig. 2B show that the hybrid proteins from Ser
33
 through Ser
543
 lined up according to 
increasing molecular mass as the fusion sites became closer to the C-terminal end of the 
full-length protein. Expression of the signal-less BlaM fused at its C-terminus with the 
N-terminal half of AspT (Fig. 2B, lane 4) was observed; however, expression of BlaM fused at 
the C-terminus with the full-length of AspT was significantly low (Fig. 2B, lane 5). Signal-less 
BlaM fused at its C-terminus with the N-terminal half of AspT, and AspT–BlaM hybrid proteins 
with fusion locations at Gly
62
, Leu
151
, Ser
386
, Lys
411
, Gln
427
, Ala
436
, Ser
448
, Ser
452
, Cys
476
 and the 
C-terminal end Ser
543
 of AspT showed carbenicillin resistance (100–800 g/ml), suggesting that 
the fusion sites including both N and C-termini face the periplasm. Since expression of 
signal-less BlaM fused with the full-length of AspT was significantly low, the low expression 
levels would be responsible for the carbenicillin sensitivity of cells expressing this fusion. Thus, 
we excluded this fusion from our predictions. On the contrary, the remaining fusions with 
junction sites at Ser
33
, Lys
87
, Ala
198
, Ala
273
, Glu
348
, Ser
366
, and Glu
506
 were sensitive to 
carbenicillin at concentrations <50 g/ml, indicating that these fusion sites are most likely 
located on the cytoplasmic side of the membrane. Thus, the results obtained with BlaM fusions 
are in good agreement with those obtained with AspT–PhoA hybrid proteins (Table 1). 
To our knowledge, transporters in which both the N and C-termini are localized toward the 
periplasm are scarcely reported. Although we had constructed 6 X histidine-tag fusions at the N 
and C -termini of AspT prior to the PhoA and BlaM fusion experiments reported here, we did 
not succeed in expressing the two histidine-tag fusions (data not shown). Since the N and C 
-termini of the full-length of AspT face the periplasmic side according to the results of the PhoA 
and BlaM fusion analyses, positive charges in 6 X histidine-tag might inhibit traversal of the 
two termini across the membrane and consequently be responsible for the failure in expression 
of the two terminal histidine-tag fusions. 
The results of AspT–PhoA fusion analysis also indicated the possibility of a reentrant loop 
(Glu
424–Ser448) that seems to be embedded in the cytoplasmic membrane from the outside 
between TMS6 and TMS7, for the following reasons. Cells expressing PhoA fused with AspT at 
Glu
424
 and Ser
448
 obviously had alkaline phosphatase activity, suggesting a periplasmic 
localization of these two sites. However, cells expressing PhoA fused at Gln
427
 and Ala
436
 of 
AspT showed intermediate levels of alkaline phosphatase activity. The 23-amino acid-chain 
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between Glu
424
 and Ser
448
 is not long enough to traverse the cytoplasmic membrane twice. 
Similar reentrant loops have been found in other transporters and channels, including synaptic 
glutamate transporter GLT-1 [28, 29] and potassium channel KcsA [30] . However, since 
AspT–BlaM fusions joined at Gln427 and Ala436 of AspT showed carbenicillin resistance, the 
possibility that the region between Glu
424
 and Ser
448
 has periplasmic localization cannot be ruled 
out. Fusion methods that use reporter proteins having a larger molecular mass do not yet have 
enough resolution to analyze the location of this putative reentrant loop. In addition to the 
periplasmic localization of the two terminal ends of AspT, its large cytoplasmic loop consisting 
of 183 amino acid residues gives a characteristic feature to the two-dimensional structure of 
AspT among known secondary transporters whose membrane topologies have been 
biochemically analyzed or computationally predicted. To our knowledge, the large cytoplasmic 
loop of AspT is significantly longer than those observed in other secondary transporters such as 
CitS [20] and GltT [31] . We found 10 probable AspT-orthologous genes in recent bacterial 
genome information by using the tBlastn network service, and all of them are consistent with 
large cytoplasmic loops similar to that of Tetragenococcal AspT, according to the TMS 
prediction program SOSui (data not shown). 
Our new topological model of AspT, based on the data shown in the present study (Fig. 3), 
represents a new class of secondary transporter, an AAE family previously predicted by Saier et 
al.  (http://www.biology.ucsd.edu/~msaier/transport/) according to its amino acid sequence and 
hydropathy [4] . In addition, the results of helical wheel analysis (data not shown) tentatively 
suggested the presence of a positively charged residue (Arg
76
) within TMS3 and charged Lys
481
, 
Glu
483
, and Asp
495
 residues in TMS7 (Fig. 3). The charged residues in the hydrophobic sectors 
imply that TMS3 and TMS7 form a part of the substrate translocation pathway. 
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Figure 1. Hydropathy analysis of T. halophilus AspT. The hydropathy plot was calculated
with the algorithm of Eisenberg [21] using a window size of 15 residues.
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Figure 2. Western blot analysis of AspT-PhoA fusion proteins expressed in E. coli LMG194
(A) and AspT-BlaM fusion proteins expressed in E. coli XL-3 (B). Whole-cell lysates were
prepared, subjected to polyacrylamide (10% or 12.5%) gel electrophoresis in the presence of
SDS, electroblotted onto a polyvinylidene difluoride membrane, and visualized with
monoclonal antibodies against alkaline phosphatase (A) or polyclonal antibodies against β-
lactamase (B). The samples are coded here according the fusion site (e.g., Ser33 indicates
residues 1-33 of AspT fused with PhoA). (A) Lane 1, molecular weight markers (Western
doctor); lane 2, no plasmid; lane 3, pBADphoA ; lane 4, C-Ser33; lane 5, C-Gly62; lane 6, C-
Lys87; lane 7, C-Ala126; lane 8, C-Lue151; lane 9, C-Ala198; lane 10, C-Ala273; lane 11, C-
Glu348; lane 12, C-Ser366; lane 13, C-Ser386; lane 14, C-Lys411; lane 15, C-Gln427; lane
16, C-Ala436; lane 17, C-Ser448; lane 18, C-Ser452; lane 19, C-Cys476; lane 20, C-Glu506;
lane 21, C-Ser543. (B) Lane 1, molecular weight markers (Western doctor); Lane 2, pYZ4;
Lane 3, BlaM; lane 4, N-AspT (half); lane 5, N-AspT (full-length); lane 6, C-Ser33; lane 7,
C-Gly62; lane 8, C-Lys87; lane 9, C-Ala126; lane 10, C-Lue151; lane 11, C-Ala198; lane 12,
C-Ala273; lane 13, C-Glu348; lane 14, C-Ser366; lane 15, C-Ser386; lane 16, C-Lys411; lane
17, C-Gln427; lane 18, C-Ala436; lane 19, C-Ser448; lane 20, C-Ser452; lane 21, C-Cys476;
lane 22, C-Glu506; lane 23, C-Ser543.
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Figure. 3 Topological model of AspT, based on the results of PhoA fusions (A)
and BlaM fusions (B). (A) PhoA fusion sites are indicated by black circles.
The numbers in parentheses indicate unit of PhoA activity (units). (B) BlaM
fusion sites are indicated by black circles. The numbers in parentheses
correspond to the MIC (µg/ml) of β-lactam. Positively charged residues and
negatively charged residues are indicated by open circles and open boxes,
respectively.
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CHAPTER III 
 
ABSTRACT 
The Gram-positive lactic acid bacterium Tetragenococcus halophilus catalyzes the 
decarboxylation of L-aspartate (Asp) with release of L-alanine (Ala) and CO2. The 
decarboxylation reaction consists of two steps: electrogenic exchange of Asp for Ala catalyzed 
by an aspartate:alanine antiporter (AspT), and intracellular decarboxylation of the transported 
Asp catalyzed by an L-aspartate--decarboxylase (AspD). AspT belongs to the newly classified 
aspartate:alanine exchanger (AAE) family (TC# 2.A.81) of transporters. In this study, we are 
interested in the relationship between the structure and function of AspT, and thus analyzed the 
topology by means of the substituted-cysteine accessibility method (SCAM) using the 
impermeant, fluorescent thiol-specific probe Oregon Green 488 maleimide (OGM) and the 
impermeant, nonfluorescent thiol-specific probe 
[2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET). We generated 23 
single-cysteine variants from a 6x histidine-tagged cysteine-less AspT template. A cysteine 
position was assigned an external location if the corresponding single-cysteine variant reacted 
with OGM added to intact cells, and a position was assigned an internal location if OGM 
labeling required cell lysis. The topology analyses revealed that AspT has a unique topology; the 
protein has 10 transmembrane helices (TMs), a large hydrophilic cytoplasmic loop (about 180 
amino acids) between TM5 and TM6, N- and C-termini that face the periplasm, and a positively 
charged residue (arginine76) within TM3. Moreover, the three-dimensional (3D) structure 
constructed by means of the Full Automatic Modeling System (FAMS) indicates that the large 
hydrophilic cytoplasmic loop of AspT possesses a TrkA_C domain and a TrkA_C-like domain, 
and that the 3D structures of these domains are similar to each other even though their amino 
acid sequences show low similarity. 
 
 
INTRODUCTION 
In some strains of the lactic acid bacterium Tetragenococcus halophilus, a proton-motive 
force (PMF) is generated by the combined action of an intracellular L-aspartate decarboxylation 
catalyzed by an L-aspartate--decarboxylase (AspD) and an electrogenic aspartate1-:alanine0 
exchange reaction catalyzed by an aspartate:alanine antiporter (AspT, TC# 2.A.81.1.1). The 
generated PMF is sufficiently high to drive ATP synthesis via the bacterial F0F1 ATPase. This 
combination of PMF and ATP synthesis has been proposed as a proton-motive metabolic cycle, 
and the prototype model is found in Oxalobacter formigenes (3, 8, 32). 
In previous works using proteoliposomes, we found that the aspartate:alanine exchange 
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catalyzed by AspT is electrogenic (1, 2). The biochemical features of substrate transport by 
AspT indicate that it can be classified as a conventional secondary transport protein and that it is 
an electrogenic antiporter similar to the prototype precursor:product exchanger, OxlT, the 
oxalate:formate antiporter, which is a member of the major facilitator superfamily (MFS), from 
O. formigenes (3, 8, 32, 37). 
Although AspT and OxlT exhibit similar transport properties, such as electrogenic 
precursor:product antiport behavior and electroneutral self-exchange, their putative amino acid 
sequences show no similarity. In addition, AspT belongs to the newly classified 
aspartate:alanine exchanger (AAE) family (TC# 2.A.81) of transporters in the transporter 
classification (TC) system (http://www.tcdb.org/index.php) developed by Milton H. Saier Jr. et 
al. The TC system has been approved by the International Union of Biochemistry and Molecular 
Biology (http://www.chem.qmul.ac.uk/iubmb/) as a classification system for membrane 
transport proteins. 
Recently, the results of a BLAST (http://www.ncbi.nlm.nih.gov/BLAST/ (5)) search of the 
nucleotide sequence of the aspT gene and the amino acid sequence of the AspT protein against 
current nucleotide and protein databases have suggested that AAE family transporters are 
conserved in many bacterial species (11, 20). AspT is the only functionally characterized protein 
belonging to the AAE family (2). The putative broad distribution of AspT orthologues and 
paralogues in bacteria suggests that additional biochemical study of AspT can be a valuable part 
of the ongoing investigation of membrane transport. 
We have studied the topology of AspT by using alkaline phosphatase (PhoA) and -lactamase 
(BlaM) fusion methods (34), and our results suggested that AspT has a unique topology. 
However, the structure of the C-terminal half of AspT remains ambiguous because fusion 
methods that use reporter proteins having large molecular masses do not yet have resolution that 
is high enough to provide a detailed topology of the transporter. 
Over the past decade, the membrane topology of primary and secondary transporters has been 
studied extensively by means of the substituted-cysteine accessibility method (SCAM), which 
involves cysteine-scanning mutagenesis in combination with thiol-specific labeling of single 
cysteines artificially introduced into the target membrane proteins. This method has been used 
to elucidate the membrane topology of, for example, OxlT (18, 19, 45, 46), the tetracycline:H
+
 
transporter (41), the Na
+
:H
+
 antiporter (29), lactose permease (27), the multidrug transporter 
P-glycoprotein (31), and the glutamate transporter GLT-1 (21). Therefore, we used this method 
to elucidate the detailed membrane topology of AspT. 
First, we used SCAM to analyze the orientation of TM3. Our PhoA- and BlaM-fusion studies 
indicated that there is probably an isolated charged residue (arginine76) in the middle of TM3. 
The presence of an uncompensated charge within a hydrophobic transmembrane region is 
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generally thought to destabilize the structure of membrane proteins (15, 30). We next examined 
the orientations of the remaining transmembrane segments in AspT by using SCAM to elucidate 
the unknown structure of the C-terminal half of AspT. The topology analyses revealed that AspT 
does indeed have a unique topology; the protein has 10 TMs, a large hydrophilic cytoplasmic 
loop (about 180 amino acids) between TM5 and TM6, and N- and C-termini that face the 
periplasm. Computations using recent genome data have predicted that the AAE family is 
composed of membrane proteins possessing a unique membrane topology (11), and our 
topology analyses support this prediction. 
We used the Full Automatic Modeling System (FAMS) 
(http://www.pharm.kitasato-u.ac.jp/fams/index.html (24, 35)) to carry out homology modeling 
of the three-dimensional structure of the large hydrophilic cytoplasmic loop of AspT. The 
modeling predicted that the loop would possess two alpha-beta complex structures (CATH 
Protein Structure Classification, http://cathwww.biochem.ucl.ac.uk/latest/index.html (36)). 
Furthermore, we produced and purified recombinant protein of the large hydrophilic 
cytoplasmic loop region to measure the circular dichroism (CD) spectrum of this protein. The 
CD analysis confirmed that the loop contained -helices and -structures. 
 
 
MATERIALS AND METHODS 
Materials, cells, and expression plasmids L-[2,3-
3
H]Aspartic acid (1.07 GBq/mmol) was 
purchased from Amersham-Pharmacia Biotech (Piscataway, USA). 
1-O-n-Octyl--D-glucopyranoside (OG) was obtained from Nacalai Tesque (Kyoto, Japan). 
Escherichia coli phospholipid was provided by Avanti Polar Lipids (Alabaster, USA) (7). 
Oregon Green 488 maleimide (OGM) was purchased from Invitrogen Co. (Carlsbad, USA), and 
[2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET) was purchased from 
Toronto Research Chemicals (Toronto, Canada). E. coli strain XL1 blue harboring pMS421 
(Spec
r
 LacI
q
), referred to as strain XL3 (3), was used for expression of the asp operon with 
pTrc99A (Amersham-Pharmacia Biotech).  
Construction of histidine insertion variants AspT 6x histidine insertion variants were 
constructed with a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, USA) in 
plasmid pBluescript II KS(+) (Stratagene) including the gene for AspT (pBlueAspT). TABLE I 
lists the hydrophilic loop domains into which the 6x histidine-tag insertions were made. The 
oligonucleotides contained 5'-CATCATCATCATCATCAT-3' sequences as 6x histidine codons. 
For hydrophilic loop 7, which contains one endogenous histidine residue, the corresponding 
oligonucleotide utilized one endogenous histidine codon as part of the string of 6x histidine 
codons. 
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Site-directed mutagenesis Site-directed mutations were introduced using a QuikChange 
site-directed mutagenesis kit or the oligodeoxyribonucleotide-directed dual amber (ODA) 
method (Takara Bio, Tokyo, Japan (22)). Cysteine-less AspT-(His)6 was constructed by 
replacing three endogenous cysteine residues with alanine (C19A/C110A/C476A) in plasmid 
pBluescript II KS(+) including the gene for 6x histidine-tagged AspT (pBlueAspT-His) using a 
QuikChange site-directed mutagenesis kit. DNA fragments encoding cysteine-less AspT-(His)6 
were cloned into pTrcAsp instead of wild type (WT) AspT. Single-cysteine variants were 
constructed by the ODA mutagenesis method. The pKF 19k/18k vector (Takara Bio) harboring 
the gene of cysteine-less AspT-(His)6 was used as a DNA template for the ODA mutagenesis 
method. DNA fragments encoding AspT, in which a single cysteine had been introduced, were 
ligated back into the corresponding site of pBlue cysteine-less AspHis. DNA fragments 
encoding single-cysteine AspT-(His)6 were cloned into pTrcAsp instead of into WT AspT. The 
DNA sequences of all mutagenized AspT were verified by DNA sequencing as described 
previously (2). 
Production of WT AspT, AspT-(His)6, cysteine-less AspT-(His)6, and single-cysteine 
AspT-(His)6 A preculture of E. coli XL3 carrying pTrcAsp or pTrcAsp-His, pTrc cysteine-less 
AspT-His, and pTrc single-cysteine AspT-His was diluted 100-fold in fresh Luria-Bertani (LB) 
medium containing 30 mM D-glucose, 30 g/ml carbenicillin, and 30 g/ml spectinomycin. 
These cells were grown for 2.5 h at 37 C with shaking and were then diluted 2-fold in fresh 
Luria broth containing 30 mM D-glucose, 60 mM L-aspartate, and 1 mM pyridoxal 5'-phosphate. 
The cell suspension was incubated statically for 13 h at 37 C. At 12 h prior to cell harvest, 200 
M isopropyl--D-thiogalactoside (IPTG) was added to the cultures. 
Preparation of membrane ghosts and solubilization and reconstitution of AspT  
Membrane ghosts were prepared by an osmotic shock procedure (7). Harvested cells were 
suspended in 5 ml of a lysis solution (500 g/ml lysozyme [Seikagaku Co., Tokyo, Japan], 
40 g/ml DNase I [SIGMA, St. Louis, USA], 10 mM 
2-amino-2-hydroxymethylpropane-1,3-diol (Tris)-HCl [pH 7.5], 1 mM phenylmethyl sulfonyl 
fluoride [PMSF])] and incubated at 37 C for 30 min. Cells were disrupted by 10-fold dilution 
into 45 ml of iced distilled water. After cell disruption, the released cytoplasmic proteins were 
removed by two cycles of centrifugation and washing with iced distilled water (42). Membrane 
ghosts were solubilized (7) using 1.25% (w/v) OG in the presence of 0.4% (w/v) E. coli 
phospholipid, 100 mM KH2PO4 (pH 7) as the potassium salt, and 20% glycerol. Control extracts 
were prepared in the same way, but without added protein. These solubilized membrane proteins 
were reconstituted in a final volume of 1 ml with 800 l of detergent extracts (1.2 mg of 
protein) (or control lipid extract), 130 l of bath-sonicated liposomes (5.9 mg of E. coli 
phospholipid), and 18 l of 15% OG, with the balance made up by 100 mM KH2PO4 (pH 7) as 
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the potassium salt. After incubation for 20 min on ice, proteoliposomes (or control liposomes) 
were formed at room temperature (R.T.) by rapid injection into 20 ml of a loading buffer 
containing 100 mM KH2PO4 (pH 7) and 100 mM L-aspartate as the potassium salt. The 
substrate-loaded proteoliposomes (or liposomes) were kept at R.T. for 20 min. 
Assay of aspartate transport  Unless otherwise noted, initial rates of 
L-[2,3-
3
H]aspartate entry were measured in duplicate at 25 C by means of a filtration assay (43, 
46). Proteoliposomes were applied directly to the center of a 0.22-m pore-size GSTF Millipore 
filter (Millipore Co., Billerica, USA) and washed twice with 5 ml of chilled assay buffer (100 
mM KH2PO4 [pH 7], 100 mM K2SO4). Upon release of the vacuum, proteoliposomes were 
covered with pre-incubated assay buffer containing 0.1 mM L-[2,3-
3
H]aspartate, and the 
reaction was terminated after 1 min by filtration and washing. AspT function is usually reported 
as relative specific activity by normalization of observed rates to levels of AspT production as 
determined by immunoblot analysis (described below). 
Immunoblot analysis Detergent extracts of membrane ghosts of each of the 
single-cysteine variants and the cysteine-less parent were analyzed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). For SDS-PAGE, 45 g of proteins was used, 
and after electrophoresis, proteins were transferred to a polyvinylidene difluoride membrane 
(Nippon Genetics, Tokyo, Japan) by semidry electrophoretic blotting (Bio-Rad Laboratories, 
Hercules, USA) and probed with an anti-AspT rabbit polyclonal antibody, which was prepared 
by Operon Biotechnologies (Tokyo, Japan) using synthetic polypeptides 
(SKLPISDHLKTLYSNQ and NDVSERVGSDASPF) as antigens. AspT production was 
detected by chemiluminescence with a LAS-3000 imaging system (FUJIFILM, Tokyo, Japan), 
and signals were quantified using NIH Image (v. 1.63). Antisera were used at the following 
dilutions: anti-AspT rabbit polyclonal, 1:2000; anti-rabbit immunoglobulin G goat polyclonal 
antibody horseradish peroxidase-conjugate (StressGen Bio. Co., Victoria, Canada), 1:2000. 
Production of each AspT variant was normalized to that of the cysteine-less parental control 
found on the same gel. 
Site-directed labeling Site-specific fluorescent labeling was designed to selectively attack 
either cysteines exposed to the extracellular medium or cysteines exposed at the intracellular 
surface. To label cysteines exposed at the extracellular surface, intact cells were harvested by 
centrifugation (6000  g  30 min) and suspended in buffer A (100 mM K2SO4, 50 mM KH2PO4 
[pH 8]), and the absorbance at 530 nm was adjusted to 8.5. Then 40 M (final concentration) 
OGM was added to 5 ml of the cell suspension, and the mixture was incubated for 20 min at 25 
C. The labeling reaction was quenched by addition of 6 mM (final) -mercaptoethanol. The 
cells were collected immediately and washed three times with buffer B (100 mM K2SO4, 50 
mM 3-(N-morpholino)propanesulfonic acid [pH 7] as the potassium salt). Labeled cells were 
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then resuspended in 5 ml of lysis solution (500 g/ml lysozyme, 5 mM 
ethylenediaminetetraacetic acid, and 10 mM Tris-HCl [pH 7.5]) and incubated at 37 C for 30 
min to initiate cell rupture. Membrane ghosts were obtained by 10-fold dilution in cold distilled 
water, and cytoplasmic proteins were removed by three cycles of centrifugation (10,000  g  10 
min). These membranes served as the source of AspT for solubilization and purification 
(below). 
Cysteines exposed at the intracellular surface were identified by a two-step protocol. External 
cysteines were blocked by an initial 15-min pre-incubation of cells at 30 C in buffer A 
containing 2 mM MTSET. MTSET was removed by three cycles of centrifugation and washing 
using buffer B without -mercaptoethanol, and pre-blocked cells were used for preparation of 
membrane ghosts, as above. This procedure exposed unmodified cysteines that had faced the 
cytoplasm, and these cysteines were labeled by incubation of membrane ghosts for 20 min at 25 
C in buffer C (20 mM KH2PO4 [pH 8] as the potassium salt) containing 40 M OGM. The 
reaction was quenched with 2 mM (final) -mercaptoethanol, and the quenching was followed 
immediately by three cycles of centrifugation and resuspension, using distilled water, and by 
protein solubilization and AspT purification (below).  
In some cases, we used OGM labeling under conditions that did not discriminate between 
internal and external locations. In these tests, membrane vesicles were prepared directly, without 
blocking of the external cysteines. The vesicles were incubated for 20 min at 25 C in buffer C 
including 40 M OGM, and then the reaction was quenched as described above. 
AspT purification Protein was solubilized by resuspending the membrane vesicles in 
1 ml of solubilization buffer (50 mM Tris-HCl [pH 7], 0.75 mM PMSF, 1% Triton X-100, 0.1% 
SDS). After incubation at 4 C for 2 h on a rotary platform shaker, insoluble debris was 
removed by centrifugation in the cold (17,500  g  30 min), and AspT was purified in a 
one-step affinity procedure (17). In brief, 6x histidine-tagged AspT was precipitated with 50 l 
of Ni-NTA Superflow resin (Qiagen, Valencia, CA, USA) by means of an overnight batch 
incubation in the cold on a rotary platform shaker. The resin, with bound AspT, was washed on 
ice with a total of 3 ml of wash buffer (solubilization buffer supplemented with 200 mM sodium 
fluoride and 30 mM imidazole). AspT was eluted by a brief centrifugation in the cold using 30 
l of elution buffer (50 mM Tris-HCl [pH 7], 2% SDS, 0.5 M imidazole). 
Detection of OGM labeled protein Protein was subjected to SDS-PAGE using a 10% 
polyacrylamide gel matrix. For SDS-PAGE, 15 l of elution sample was used, and after 
electrophoresis, the gel was rinsed briefly with a destaining solution (10% glacial acetic acid, 
15% methanol). Fluorescence profiles were recorded with a LAS-3000 imaging system. After 
the fluorescence profiles were recorded, the protein content of each lane was evaluated by 
staining the same gel with Coomassie Brilliant Blue (CBB). 
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Modeling the structure of the large hydrophilic loop region A homology model of the 
large hydrophilic loop of AspT was constructed using SKE-CHIMERA (40) and FAMS 
Ligand&Complex (39). We used the amino acid sequence of the AspT from Tetragenococcus 
halophilus (accession no. Q8L3K8) as a target, and we constructed and examined a number of 
alignments derived from an eight-sequence search method using SKE-CHIMERA. In 
consideration of the sequence identities, the E-values, and the degree of agreement between the 
secondary structure elements of the target predicted by PSI-PRED (26) and the structure of 
reference protein predicted by STRIDE (16), we selected the crystal structures of the putative 
potassium-channel-related proteins from Methanothermobacter thermautotrophicus (PDB code: 
1LNQ) and from Pyrococcus horikoshii (PDB code: 1VCT) as templates. The alignments of 
target and template were generated by PSI-BLAST (6) and PSF-BLAST, respectively. 
PSF-BLAST is a variation of PSI-BLAST in which a position-specific scoring matrix 
construction process is revised using reference protein family sequences from the nonredundant 
sequence database (ftp://ftp.ncbi.nih.gov/blast/db/FASTA/nr.gz) at NCBI. The structure of the 
target was predicted by FAMS Ligand&Complex based on these alignments. 
Construction of the histidine-tagged large hydrophilic loop expression vector 
To clone the DNA fragment encoding the AspT large hydrophilic loop region (Arginine 
178-Asparagine 361) into the pCold II vector (Takara Bio, Tokyo, Japan), the plasmid pCold II 
vector was digested with reaction endonucleases Nde I and Xba I to yield a DNA fragment of 
4.33 kbp. The DNA fragment of the loop region was amplified from pBlueAspT by using a pair 
of mutagenic oligonucleotide primers. The amplified DNA fragment from the primer set was 
designed to introduce an Nde I site at the 5 end and an Xba I site at the 3 end to promote 
subsequent ligation. PCR product (570 bp) was digested with the reaction endonucleases Nde I 
and Xba I. Each fragment was isolated from an agarose gel. Ligation reactions were performed 
by using the Nde I–Xba I–digested PCR product and the pCold II fragment at various 
vector:insert molar ratios. After the ligated product was transformed into E. coli DH5, 
recombinant clones were selected on LB medium plates containing carbenicillin. Plasmid DNA 
was prepared from carbenicillin-resistant colonies, and the DNA sequence of the insert in the 
new plasmid was confirmed by DNA sequencing, as described previously (2). The plasmid was 
then transformed into E. coli strain BL21(DE3) for expression studies. 
Expression and purification of the histidine-tagged AspT large hydrophilic loop region  
An overnight culture of E. coli BL21(DE3) carrying pCold II vectors harboring the gene of 
the AspT large hydrophilic loop region (Arginine 178-Asparagine 361) was inoculated into 200 
ml of LB medium, and the culture was allowed to grow at 37 C with shaking until an OD600 of 
0.6 was reached. The culture was cooled immediately under static conditions at 15 C for 
approximately 30 min. The cells were then induced with 0.4 mM IPTG and grown at 15 C with 
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shaking for approximately 24 h. We used SDS-PAGE to confirm production of recombinant 
protein of the AspT large hydrophilic loop region. 
The recombinant AspT large hydrophilic loop region was purified at 4 C. Cells were 
collected by centrifugation at 6000  g for 20 min and resuspended in 10 ml of lysis buffer (50 
mM Tris-HCl buffer at pH 7.0, 200 mM NaCl, and 10 mM PMSF). The sample was then lysed 
by sonication on ice by means of 15-s pulses separated by 30-s intervals until the solution 
became transparent. The resultant lysate was centrifuged at 10,000  g at 4 C for 20 min, and 
the supernatant was collected and placed on ice. Ni-NTA Superflow resin (Qiagen, Valencia, CA, 
USA) was equilibrated with 10 ml of wash buffer (50 mM Tris-HCl buffer at pH 7.0, 200 mM 
NaCl, 10 mM PMSF, and 30 mM imidazole), and the supernatant containing the AspT large 
hydrophilic loop region was applied to the equilibrated resin. After washing five times with 20 
ml of wash buffer, 6x histidine-tagged protein was eluted with 1 ml of elution buffer containing 
500 mM imidazole. The N-terminal amino acid sequence of the purified protein was analyzed 
with an Applied Biosystems 491HT protein sequencer (Applied Biosystems, Foster City, USA). 
Circular dichroism measurements of the AspT large hydrophilic loop region 
Circular dichroism spectra of the AspT large hydrophilic loop region were measured by the 
method of Ichishima et al. (23). The circular dichroism spectra were recorded over the 190–250 
nm wavelength region on a J-720 circular dichroism spectrometer (JASCO International, Tokyo, 
Japan) in a 1-mm quartz cuvette (GL Science, Tokyo, Japan). The temperature was kept at 25 °C, 
and the sample compartment was continuously flushed with N2 gas. Spectrum was the average 
of 10 scans, using a bandwidth of 1 nm, a step width of 1 nm, and a 4-s averaging per point. The 
spectra were corrected by using a reference solution without the protein. A protein concentration 
of 5.0 M in distilled water was used. Results are expressed as mean residue ellipticities in deg 
cm
2
 dmol
-1
. The existence of the -helix and -structure of the AspT large hydrophilic loop 
region was confirmed by means of the SSE-338 program (44). 
 
 
RESULTS 
Creation of a fully functional histidine-tagged variant of AspT To construct 6x 
histidine-tagged AspT, we fused the 6x histidine-tag to the N-terminus or to the C-terminus, as 
has been done for many other membrane proteins whose topologies have been experimentally 
determined. Immunoblot and functional analyses of the 6x histidine-tagged AspT variants 
indicated that the production levels and activities of the variants were significantly reduced 
relative to those of the wild type and that the variants were therefore not suitable for 
cysteine-scanning experiments (TABLE I).  
Therefore, we constructed four 6x histidine-tagged insertion variants with the tag inserted in 
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putative cytoplasmic and periplasmic loop regions predicted by the results of topology analysis 
based on the fusion methods described previously. Immunoblot and functional analyses of the 
insertion variants showed that only one variant, in which the 6x histidine-tag was inserted into 
the putative cytoplasmic loop 5, maintained production and activity levels that were nearly the 
same as those of the wild-type AspT (TABLE I). In addition, the results of the functional 
analysis of this insertion variant using proteoliposomes suggested that this variant exhibits 
aspartate:aspartate self-exchange and electrogenic aspartate:alanine heterologous exchange 
activities (Supplemental FIG. 1). 
We designed a purification scheme for this 6x histidine-tagged variant by using Ni-NTA 
Superflow resin. The 6x histidine-tagged variant was successfully purified by this method, 
which could also be used to purify single-cysteine variants of 6x histidine-tagged AspT for 
cysteine-scanning mutagenesis as described below. 
Membrane topology analyzed by site-directed fluorescence labeling Prior to 
cysteine-scanning mutagenesis of AspT, we constructed a cysteine-less variant of AspT from the 
6x histidine-tagged AspT by substituting alanine for all three endogenous cysteine residues 
(cysteine19, cysteine110, and cysteine476). Because the cysteine-less AspT produced in E. coli 
strain XL3 (3) exhibited activities that were almost the same as those of the 6x histidine-tagged 
AspT in proteoliposomes (TABLE II), we used the cysteine-less variant as a starting material for 
the generation of a variant series with single cysteine substitutions. TABLE III describes the 
single-cysteine variants that served as targets in the study of AspT topology. To establish the 
topology of AspT, we examined 23 variants in which cysteines were placed either at the ends of 
putative transmembrane segments or in the loops that connect the transmembrane segments. 
Because these variants retained normal or near-normal (20%, (45)) specific activities after 
reconstitution in proteoliposomes (TABLE III), we assumed that the targeted cysteines did not 
significantly perturb the structure of AspT. Thus, we believe that the topology of each of these 
variants reflects the location of the original residues in the cysteine-less variant and in wild-type 
AspT. 
To probe AspT topology, we employed a strategy successfully used to establish the membrane 
topology of OxlT (18, 45). Fusion analysis of AspT suggested the presence of 8 TMs 
(TM1–TM8) and that arginine76 may lie within TM3 (34). Because the peak hydropathy in the 
area surrounding TM3 is marginally lower than that in other TMs, our initial experiments were 
designed to establish whether this region actually traverses the membrane. We established this 
by examining the accessibility to an impermeant, fluorescent thiol-specific probe (OGM) of 
single-cysteine targets predicted to be either at the extracellular surface or at the intracellular 
surface. Evidence that a targeted position was exposed to the periplasm was obtained when the 
single-cysteine variant was modified by exposure of intact cells to OGM. By contrast, 
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cytoplasmic positions were identifiable if cysteine modification took place only after cell lysis. 
As a control experiment to validate these interpretations, the external target cysteine residue in 
each AspT variant must be protected from OGM by pretreatment of intact cells with the 
impermeant, nonfluorescent thiol-specific probe MTSET prior to OGM treatment of cell 
membranes from disrupted cells. The protection procedure had no effect on the labeling of 
positions assigned to the cytoplasmic surface.  
In the initial experiments, we chose two single-cysteine variants, T59C and A90C; the high 
levels of production and activity (TABLE III) of these variants supported the idea that for the 
most part they retain the structure of wild-type AspT. Fusion methods predicted that residues 
threonine59 (T59C) and alanine90 (A90C) of AspT are located on opposite sides of the 
transmembrane segment previously assigned as TM3 (34). After the intact cells independently 
producing T59C and A90C were directly exposed to OGM, both the T59C and A90C proteins 
could be readily purified, but only the T59C protein contained the fluorescent label (FIG. 1A, 
lanes 1). In contrast, when extracellular cysteines were first protected with MTSET, subsequent 
exposure of isolated membranes to OGM yielded fluorescent labeling of the A90C protein but 
not the T59C (FIG. 1A, lanes 2). Moreover, the T59C that was not pretreated with MTSET was 
efficiently labeled with OGM, which suggests that MTSET can selectively label and 
consequently protect external cysteines (FIG. 1A, lanes 3). 
These observations lead to the following two conclusions. First, positions 59 and 90 are 
clearly located on opposite membrane surfaces (FIG. 1B); the former faces the periplasm, and 
the latter is exposed to the cytoplasm. This result confirms the putative topology derived from 
fusion analysis of this region (34) and verifies the existence of TM3. Second, the OGM-labeling 
profiles of T59C and A90C confirm that the cysteine-scanning method employed in the 
experiments can be used to determine AspT topology. 
Topology of AspT  The topological analysis of AspT single-cysteine variants is 
summarized in FIGs. 2 and 3, which show results for all the examined positions (also see 
TABLE III) together with a representative OGM-labeling pattern for each cysteine targeted in 
an intracellular or extracellular loop and in the N- or C-terminus. In particular, positions 
assigned to the extracellular surface were readily labeled by the addition of OGM to the intact 
cells (FIG. 2, bottom, left lanes). This labeling pattern clearly contrasts with that of the putative 
intracellular cohort, all of which were accessible by OGM only after cell lysis (FIG. 2, bottom, 
right lanes). The OGM-labeling efficiency of the T472C variant was markedly low (FIG. 2, 
bottom, T472C right and left lanes). However, OGM labeling of T472C was detected only after 
MTSET blocking, when the detection sensitivity of the LAS-3000 imaging system was 
increased (data not shown). The low labeling efficiency of T472C might be attributable to the 
possibility that T472C is located close to the cytoplasmic side of the membrane. We concluded 
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that AspT has a minimum of 10 TMs, N- and C-termini that face the periplasm, and a large 
hydrophilic loop between the 10 TMs (that is, a 5 TMs–large loop–5 TMs structure). 
Modeling of the large hydrophilic loop of AspT We next modeled the large hydrophilic 
loop region of AspT. The crystal structures of the putative potassium-channel-related proteins 
from M. thermautotrophicus (PDB code: 1LNQ, (25)) and P. horikoshii (PDB code: 1VCT) 
were selected as templates. In Supplemental FIG. 2 we show the alignments of AspT and the 
reference proteins, as well as the putative secondary structure of AspT predicted by PSIPRED 
(26) and the secondary structure of the reference proteins assigned by STRIDE (16). The 
sequence identities between AspT and its reference proteins are very low (AspT domain 1-MthK, 
15.7%; AspT domain 2-PHO0236, 10.2%), but the E-values of these alignments (AspT domain 
1-MthK, 4e
-23
; AspT domain 2-PHO0236, 1e
-32
) are low enough to put confidence in modeling. 
In addition, the agreement between the secondary structure predicted for AspT and the 
secondary structure of MthK is good. In the resulting model, we found two alpha-beta complex 
structures (domain 1, Valine208–Phenylalanine277; domain 2, Threonine283–Glutamine352) in 
the large hydrophilic loop region of AspT (FIG. 4A, B). 
Circular dichroism measurements of the AspT large hydrophilic loop region To 
support the prediction that the large hydrophilic cytoplasmic loop contained alpha-beta complex 
structures, we measured the CD spectrum of a histidine-tagged recombinant protein of the loop 
region (Arginine 178-Asparagine 361) after purification with a Ni-NTA column (FIG. 5A, B). 
The CD spectrum indicated that the loop region had a secondary structure that included 
-helices and -structures, as predicted by the FAMS. 
 
 
DISCUSSION 
To understand the mechanism of substrate transport by AspT, functional and structural 
information about AspT is required. Various algorithms can be used to predict the likelihood that 
a polypeptide forms a membrane-spanning -helix. The use of various programs to predict the 
AspT membrane topology from hydropathy profiles generated different models, and the 
segments having hydrophobicity in the middle range were ambiguously predicted.  
To verify the in-silico topology prediction for AspT, we carried out biochemical topology 
analyses of AspT (34). For bacterial, yeast, and mammalian proteins, this phase of analysis is 
most often based on the use of a reporter system in which a series of C-terminal deletions of an 
interested protein is fused with a reporter protein at the C-terminus of each deletion mutant. The 
localization of the reporter is easily determined by phenotypic tests (13, 14, 33). Although this 
experimental approach can often generate a satisfactory model, the general mechanisms of 
topology formation for membrane proteins are not well understood. For this reason, it is 
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sometimes questionable whether fusion methods that use reporter proteins having large 
molecular masses correctly reflect the native protein topologies.  
As an alternative to fusion methods, extensive studies have been performed over the past 
decade to elucidate the detailed membrane topology of primary and secondary transporters by 
means of the substituted-cysteine accessibility method (SCAM) (12, 28, 47). SCAM was first 
introduced by Karlin et al. to study ion-channel lining residues of the acetylcholine receptor 
channel (4) and then was expanded to other multiple transmembrane proteins. By using single 
cysteine mutagenesis in combination with a neutral or charged sulfhydryl reagent, SCAM can 
precisely locate the position of the introduced cysteine residue. This technique has proved to be 
applicable to high-resolution biochemical topology analyses of membrane proteins, because the 
introduction of cysteine residues is minimally invasive and has little effect on the structure and 
function of the target membrane protein.  
We used affinity purification of histidine-tagged AspT along with cysteine-scanning 
mutagenesis and impermeant fluorescent and nonfluorescent thiol-specific probes. Taken 
together, these tools allowed us to document residue accessibility and therefore topology by 
examining the fluorescence of the purified protein. Topology analyses based on selective 
labeling of external and internal cysteines depend on the use of an impermeant fluorescent probe, 
and for this purpose we selected OGM, a maleimide-linked reporter having both acidic hydroxyl 
(pKa = 4.7) and carboxyl (pKa < 5) functional groups. The modest molecular size (460 Da) and 
the charged nature of this probe suggested that it would penetrate the outer membrane of E.coli 
but not the plasma membrane, and the presumption was supported by the following two 
observations. First, when OGM was used to treat intact cells, a cysteine (T59C) expected to be 
exposed externally was readily labeled, whereas a cysteine (A90C) expected to be exposed 
internally was not labeled (FIG. 1A, lanes 1). Second, we could also show that the external 
cysteine (T59C) was protected by treatment of the cells with MTSET and that there was no 
effect on subsequent OGM reactivity of the internal target (A90C) (FIG. 1A, lanes 2). The 
reactivity of variants T59C and A90C to these impermeant probes clearly indicated that the two 
positions are located on opposite membrane surfaces (FIG. 1B): A90C faces the cytoplasm and 
T59C the periplasm, as predicted by the initial analysis via fusion methods (34). 
Using this strategy, we analyzed 23 single-cysteine AspT variants in which each target 
cysteine residue is located at either the internal or the external surface (TABLE I and FIGs. 2 
and 3). The present topological assignments suggested that the N- and C-termini of AspT face 
the periplasm and that AspT has a large cytoplasmic loop (about 180 amino acids) between TM5 
and TM6 (FIG. 3). These results are consistent with the topology predicted by fusion methods 
(34). However, this study revealed that the C-terminal region—the topology of which was not 
unambiguously determined by fusion methods, as described above—forms five transmembrane 
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-helices. This result suggests that fusion of large-molecular-mass reporter proteins with target 
proteins disorders the native structure of AspT and interferes with topology prediction by means 
of the fusion methods. 
In the present study, we demonstrated that AspT has a unique topology: N- and C-termini that 
face the periplasm and a large hydrophilic loop in the center of 10 TMs (that is, a 5 TMs–large 
loop–5 TMs structure). To our knowledge, transporters in which the N- and C-termini face the 
periplasm are rare. Although we constructed 6x histidine-tagged fusions at either the N-terminus 
or the C-terminus, we did not succeed in producing the two 6x histidine-tagged fusions (TABLE 
I). The positive charges in the 6x histidine tag may have inhibited traversal of the two termini 
across the membrane and have consequently been responsible for the failure to produce the two 
terminal histidine-tagged fusions. Therefore, we constructed variants with 6x histidine-tags 
inserted into putative loop regions, and we succeeded in obtaining one insertion variant with 
production and activity levels nearly the same as those of wild-type AspT (TABLE I). By means 
of functional analysis using proteoliposomes, we verified that this variant had 
aspartate:aspartate self exchange and electrogenic aspartate:alanine exchange activities 
(Supplemental FIG. 1). Moreover, we could purify this variant via Ni-NTA Superflow resin. We 
propose that this method will be useful for the study of membrane proteins for which 
histidine-tagged fusions at the N- or C-terminus are not active. 
The new topological model of AspT based on our data (FIG. 3) represents a new class of 
secondary transporter in terms of topology. Interestingly, like OxlT, AspT catalyzes 
precursor:product exchange reactions, but the structure of AspT is entirely different from that of 
OxlT, which is a member of the MFS and has 12 TMs with cytoplasmic N- and C-termini (45). 
In addition, our results suggest the presence of a positively charged residue (arginine76) within 
TM3. The presence of a charged residue in the hydrophobic sector implies that TM3 forms a 
part of the substrate translocation pathway. To determine the substrate transport mechanism of 
AspT, on-going studies will focus on using cysteine-scanning mutagenesis to locate 
transmembrane helices that form putative substrate translocation pathways. 
We found 90 aspT orthologues, such as yidE and ybjL of E. coli, in 60 bacterial or 
archaebacterial genomes (20). All the putative AspT orthologues possess the typical conserved 
AAE domains (PF06826 Asp-Al_Ex, http://www.sanger.ac.uk/cgi-bin/Pfam/getacc?PF06826; 
IPR006512 YidE/YbjL duplication, http://www.ebi.ac.uk/interpro/IEntry?ac=IPR006512) listed 
in the Pfam database (http://www.sanger.ac.uk/Software/Pfam/) and the InterPro database 
(http://www.ebi.ac.uk/interpro/index.html). Analyses of hydropathy and sequence alignment of 
the AspT orthologues suggest that most of them have 9–11 TMs and a large hydrophilic loop 
centered between these TMs. It was computationally supposed that these large hydrophilic loops 
of the AspT orthologues possess one or two TrkA_C domains (PF02080 TrkA_C domain, 
43 
 
http://www.sanger.ac.uk//cgi-bin/Pfam/getacc?PF02080; IPR006037 TrkA_C, 
http://www.ebi.ac.uk/interpro/IEntry?ac=IPR006037) (11) found in the regulatory subunit TrkA 
of the bacterial potassium-uptake system (9). 
We carried out homology modeling of the three-dimensional structure of the large hydrophilic 
loop region of AspT by means of FAMS (24, 35). We found that the loop possessed two 
alpha-beta complex structures (FIG. 4A, domain 1, Valine208–Phenylalanine277; FIG. 4B, 
domain 2, Threonine283–Glutamine352). Furthermore, we produced and purified recombinant 
protein of the loop region (Arginine 178-Asparagine 361) (FIG. 5A). The CD spectrum of the 
recombinant protein was analyzed, and the results suggested that the recombinant protein had 
secondary structures such as -helices and -structures (FIG. 5B). Although we should note that 
the structure of a partial peptide could not always be the same as that in a whole protein, these 
results appear to support our homology modeling of the cytoplasmic big loop. 
Interestingly, the two alpha-beta complex structures modeled by FAMS had similar 
three-dimensional structures (FIG. 4C). The root mean square deviation (RMSD) of these 
structures was 1.29Å, and the Z-Score was 5.2, although the sequence identity of these 
structures was very low (10.3%) (Supplemental FIG. 3). Moreover, domain-search analysis of 
amino-acid sequence homology by means of InterProScan Sequence Search 
(http://www.ebi.ac.uk/InterProScan/ (10)) suggested that AspT had only one TrkA_C domain, at 
the N-terminal half of the large hydrophilic loop (FIG. 4A; domain 1); but the results of 
homology modeling suggested that AspT had a TrkA_C-like domain in the C-terminal half of 
the loop region (FIG. 4B; domain 2). In brief, domain 2 had the specific three-dimensional 
structure of the TrkA_C domain. 
TrkA_C domains have also been identified in members of the divalent anion:Na
+
 symporter 
(DASS) family (TC #2.A.47) (11). However, TrkA_C domains are broadly distributed in 
membrane transport proteins of archaebacteria, bacteria, and eukaryotes, but the functions of 
these domains are not well defined (9, 11). Therefore, we believe studying the structure and the 
function of the TrkA_C domains is worthwhile and that AspT is a good example of these 
membrane transport proteins. 
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experiments. 
SUPPLEMENTAL INFORMATION 
Other methods 
Preparation of membrane vesicles, solubilization, and reconstitution of AspT for the 
functional analysis of the histidine-tagged AspT variant. IPTG-induced cells and 
uninduced control cells were harvested by centrifugation and washed with 100 mM KH2PO4 
(pH 7); membrane vesicles were prepared by high-pressure lysis in the presence of 100 mM 
KH2PO4 (pH 7), as previously described (Ambudkar, S. V., and P. C. Maloney. 1984.) 
Characterization of phosphate:hexose 6-phosphate antiport in membrane vesicles of 
Streptococcus lactis. J Biol Chem 259:12576-85.) and the vesicles were stored at -80 
°
C as 
concentrated stock preparations (10 to 20 mg of protein per ml). Membrane vesicles (1 to 2 mg 
of protein) were solubilized (7) by using 1.25% (wt/vol) OG in the presence of 0.4% (wt/vol) E. 
coli phospholipid, 100 mM KH2PO4 (pH 7), 4 mM magnesium sulfate, 1 mM DTT, 0.75 mM 
PMAF, and 20% glycerol. Control extracts were prepared in the same way but without added 
protein. Reconstitution was in a final volume of 1 ml by using 400 l of detergent extract (or 
control lipid extract), 130 l of bath-sonicated liposomes (5.9 mg of E. coli phospholipid), and 
18 l of 15% OG, with the balance comprised of 1 mM DTT and 100 mM KH2PO4 (pH 7) as 
the potassium salt. After incubation for 20 min on ice, proteoliposomes (or control liposomes) 
were formed at 23 
°
C by rapid injection into 20 ml of a loading buffer containing 100 mM 
KH2PO4 (pH 7) and 1 mM DTT along with 100 mM L-aspartate (potassium as specified below). 
After an additional 20 min, Substrate-loaded proteoliposomes (or liposomes) were recovered by 
centrifugation and washing and were then resuspended in 100 mM KH2PO4 and 1 mM DTT. 
The final resuspension volume was usually 300 l, which resulted in protein and lipid 
concentrations of 50–250 g/ml and 13 mg/ml, respectively (7). 
Assay of transport  To assay for aspartate transport by 
L-[2,3-
3
H]aspartate-loaded particles, proteoliposomes were diluted 20-fold from the 
concentrated stock preparation into an appropriate volume of assay buffer (resuspension buffer 
lacking DTT) along with other required materials. After 1–3 min of preincubation at 25 °C, 
L-[2,3-
3
H]aspartate was added to a normal concentration of 100 M; and at various times, 50- to 
100-l aliquots were removed for membrane filtration (0.22-m pore-size GSTF Millipore 
filters), which was followed by two washes with 5 ml of assay buffer (7).  
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Variants Production (%)a Specific Activity (%)b
WT AspT 100.0 100.0
N-terminus 58.6 ± 1.7 54.5 ± 1.2
Loop 2 (63-64) 79.5 ± 0.3 8.6 ± 1.8
Loop 5 (331-332) 63.9 ± 1.4 101.5 ± 10.0
Loop 7 (413-414) 68.7 ± 1.4 3.6 ± 0.3
Loop 9 (512-513) 50.5 ± 2.6 9.9 ± 0.8
C-terminus 10.4 ± 4.3 32.3 ± 2.6
Production levels and specific activities of histidine-tagged AspT
variants relative to those of the wild-type (WT) AspT
TABLE I
a Production is given relative to that of the WT AspT parent (± S.D.).
b Initial rates of L-[2,3-3H]aspartate transport, normalized for levels
of AspT production, are given relative to the rate for the WT AspT
parent, whose activity was 10.6 nmol min-1 mg-1 of protein. Data
reflect mean values ± S.D. found in three independent trials. For each
histidine-tagged variant, an equal amount of protein was used for
reconstitution in L-aspartate-loaded proteoliposomes.
Variants Production (%)a Specific Activity (%)b
AspT-(His)6 100.0 100.0
Cys-less AspT 55.7 ± 0.8 74.9 ± 6.7
Production levels and specific activities of cysteine-less AspT
variants relative to those of the AspT-(His)6 variant
TABLE II
a Production is given relative to that of the AspT-(His)6 parent (±
S.D.).
b Initial rates of L-[2,3-3H]aspartate transport, normalized for levels
of AspT production, are given relative to the rate for the AspT-
(His)6 parent, whose activity was 8.37 nmol min
-1 mg-1 of protein.
Data reflect mean values ± S.D. found in three independent trials.
For each variant, an equal amount of protein was used for
reconstitution in L-aspartate-loaded proteoliposomes.
Variants Production (%)a Specific Activity (%)b Location
Cys-less AspT 100.0 100.0
A3C 98.7 ± 2.1 101.6 ± 1.5 Periplasm
S33C 108.9 ± 3.2 90.8 ± 9.2 Cytoplasm
T59C 81.2 ± 8.3 60.2 ± 1.9 Periplasm
A90C 100.7 ± 0.7 70.5 ± 5.1 Cytoplasm
L151C 98.6 ± 0.4 106.6 ± 1.3 Periplasm
S156C 63.2 ± 1.3 261.2 ± 17.8 Periplasm
P160C 85.6 ± 2.2 66.6 ± 1.1 Periplasm
M182C 86.0 ± 1.4 96.5 ± 2.3 Cytoplasm
M186C 120.6 ± 4.3 33.3 ± 0.7 Cytoplasm
L190C 95.0 ± 1.8 34.4 ± 0.4 Cytoplasm
A194C 91.1 ± 1.5 51.8 ± 4.9 Cytoplasm
S291C 105.4 ± 1.7 78.8 ± 2.2 Cytoplasm
S351C 98.2 ± 0.5 86.0 ± 3.3 Cytoplasm
S386C 94.8 ± 1.3 127.5 ± 6.7 Periplasm
Y408C 48.4 ± 2.5 140.0 ± 4.3 Cytoplasm
H412C 129.5 ± 2.3 49.3 ± 0.9 Cytoplasm
S421C 84.7 ± 1.5 121.4 ± 6.8 Cytoplasm
S448C 99.1 ± 1.3 69.4 ± 4.0 Periplasm
T472C 109.7 ± 0.6 42.5 ± 2.7 Cytoplasm
M480C 88.2 ± 0.5 59.5 ± 2.9 Cytoplasm
S486C 108.1 ± 1.7 111.6 ± 2.9 Cytoplasm
S510C 94.4 ± 1.7 49.8 ± 2.9 Cytoplasm
S543C 84.3 ± 2.8 110.4 ± 11.0 Periplasm
TABLE III
Production levels and specific activities of single-cysteine variants relative to
those of cysteine-less AspT
a Production is given relative to that of the cysteine-less parent (± S.D.).
b Initial rates of L-[2,3-3H]aspartate transport, normalized for the levels of
AspT production, are given relative to the rate for the cysteine-less parent,
whose activity was 4.24 nmol min-1 mg-1 of protein. Data reflect mean values
± S.D. found in three independent trials. For each single-cysteine variant, an
equal amount of protein was used for reconstitution in L-aspartate-loaded
proteoliposomes.
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FIG. 1 Orientation of TM3. (A) After SDS-PAGE of purified proteins, a fluorescence
profile was recorded (right panels) before the same gel was stained with Coomassie
Brilliant Blue (CBB) to reveal total protein (left panels). Lanes 1, OGM added to intact
cells; lanes 2, OGM added to membrane ghosts prepared after pretreatment of cells
with MTSET; lanes 3, OGM added to membrane ghosts prepared without pretreatment
with MTSET. (B) Deduced orientations of TM3. The black circle represents the
cytoplasmic target, A90C; the gray circle represents the periplasmic target, T59C.
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FIG. 2 Labeling of single-cysteine variants of AspT with OGM and MTSET. After
SDS-PAGE of purified proteins, a fluorescence profile was recorded (bottom panels)
before the same gel was stained with Coomassie Brilliant Blue (CBB) to reveal total
protein (top panels). Left lanes, OGM added to intact cells; right lanes, OGM added to
membrane ghosts prepared after pretreatment of cells with MTSET. The cysteine-less
AspT variant was used as a negative control in the labeling reaction. For further details,
see Materials and Methods.
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FIG. 3 Membrane topology of AspT and locations of introduced cysteines. The predicted
topology of AspT is shown together with topological assignments from site-directed
fluorescence labeling of 23 single-cysteine derivatives (TABLE III). The residues
replaced by a cysteine residue are depicted as letters enclosed in circles, with numbers
indicating the positions. Single-cysteine variants labeled by addition of OGM to the
intact cells are indicated as gray circles. Single-cysteine variants labeled by addition of
OGM to membrane ghosts prepared after pretreatment of intact cells with MTSET are
shown as black circles. Positively charged residues and negatively charged residues are
indicated as open circles and open boxes, respectively. The three cysteine residues
(cysteine19, cysteine110, and cysteine476) that were replaced by alanine are depicted as
letters in open circles. The large hydrophilic loop region is surrounded by a dashed
circle. The alpha-beta complex structures (domain 1, Valine208-Phenylalanine277;
domain 2, Threonine283-Glutamine352) predicted by means of homology modeling of
the three-dimensional structure of the loop region using FAMS are indicated in gray and
light gray, respectively, in the large hydrophilic loop region.
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FIG. 5 SDS-PAGE profile and circular dichroism spectrum of the AspT large
hydrophilic loop region. (A) SDS-PAGE profile obtained after purification of
the AspT large hydrophilic loop region (Arginine 178-Asparagine 361), as
described in Materials and Methods. The right lane contained 2 µg of the
purified loop region. Standards of the indicated masses are in the left lane. (B)
Circular dichroism spectrum recorded as described in Materials and Methods;
the spectrum represents the average of 10 scans corrected by using a reference
solution without the protein.
B CA
FIG. 4 Modeling of the large hydrophilic loop region of AspT. (A)
Superposition of the model of the AspT loop domain 1 (Valine208-
Phenylalanine277, green) and the structure of the MthK TrkA_C domain
(Methionine264-Isoleucine334, yellow). The root mean square deviation
(RMSD) of these structures is 0.38A. (B) Superposition of the model of the
AspT loop domain 2 (Threonine283-Glutamine352, green) and the structure of
the protein PH0236 TrkA_C domain (Isoleucine122-Isoleucine192, yellow).
The RMSD of these structures is 0.54Α. (C) Superposition of the model of the
AspT loop domain 1 (green) and the model of the AspT loop domain 2 (cyan).
The structures of domain 1 and domain 2 were superposed by means of the
Combinatorial Extension (CE) algorithm (38). The RMSD of these structures is
1.29A.
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Supplemental FIG. 1 Aspartate transport by proteoliposomes containing AspT or AspT-
(His)6. A detergent extract of IPTG-induced cells carrying pTrcAsp, pTrcAsp-His, or
pTrc99A was used to prepare proteoliposomes. Proteoliposomes loaded with 100 mM
KH2PO4 [pH 7], 100 mM L-aspartate were placed in a potassium phosphate buffer (100
mM K2SO4, 100 mM KH2PO4 [pH 7], 100 mM DTT) at a concentration of 10-25 µg of
protein/ml along with 0.1 mM L-[2,3-3H]aspartate. Uptake of L-[2,3-3H]aspartate by the
proteoliposomes is shown (◆ , pTrcAsp; ■ , pTrcAsp-His; +, pTrc99A). Proteoliposomes
prepared from detergent extract of IPTG-induced cells carrying pTrcasp or pTrc99A were
allowed to take up L-[2,3-3H]aspartate for 7.25 min. At the time indicated by the arrow, L-
aspartate (△ , pTrcAsp; × , pTrcAsp-His) or L-alanine (＊ , pTrcAsp; ● , pTrcAsp-His)
was added to achieve a final concentration of 15 mM or 30mM, respectively. Samples were
removed, filtered, and washed at the times indicated.
Supplemental FIG. 3 Structural alignment between domain 1 (Valine208-
Phenylalanine277) and domain 2 (Threonine283-Glutamine352). The structural
alignment of domains 1 and 2 was generated by the Combinatorial Extension (CE)
algorithm (38). The sequence identity of these structures is 10.3%.
A
B
Supplemental FIG. 2 The sequence alignment of AspT and the reference proteins. (A)
Sequence alignment between AspT domain 1 (Valine208-Phenylalanine277) and its
reference structure, MthK (PDB code: 1LNQ, (25)) (sequence identity = 15.7%, E-value =
4e-23); (B) Sequence alignment between AspT domain 2 (Threonine283-Glutamine352)
and its reference structure, hypothetical protein PH0236 (PDB code: 1VCT) (sequence
identity = 10.2%, E-value = 1e-32). The regions of AspT that were predicted to be α-helices
and β-strands by PSIPRED (26) are highlighted in red and blue, respectively. The regions of
MthK or PH0236 that were assigned as α-helices and β-strands by STRIDE (16) are
highlighted in red and blue, respectively.
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Transport mechanism of AspT, aspartate:alanine antiporter 
of Tetragenococcus halophilus. 
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CHAPTER IV 
 
ABSTRACT 
AspT, the aspartate:alanine antiporter of Tetragenococcus halophilus, is the prototype of the 
aspartate:alanine exchanger (AAE) family of transporters. Previous work on AspT suggests that 
it has a unique topology: 10 transmembrane domains (TMs) and a large, hydrophilic 
cytoplasmic loop (about 180 amino acids) between TM5 and TM6. Because TM3 has many 
amino acid residues that are conserved among members of the AAE family and because TM3 
contains some hydrophilic residues, it is thought to be located near (or to form part of) the 
substrate-translocation pathway that includes the binding site for the substrates. To elucidate the 
role of TM3 in the transport process, we carried out cysteine-scanning mutagenesis on TM3. 
Marked defects in AspT function were observed upon replacement of tyrosine 75 or serine 84 
by cysteine. Three other variants (G74C, R76C, and S83C) showed markedly reduced 
aspartate-transport activities. The amino- and carboxyl-terminal variants of TM3 could be 
labeled with Oregon Green maleimide (OGM), whereas cysteines close to the periplasmic face 
(residues 64–75) were not labeled. These results suggest that TM3 has a hydrophobic central 
core on the periplasmic face, and that hydrophilic residues on the cytoplasmic half of TM3 
participate in the formation of an aqueous cavity in membranes. Furthermore, the presence of 
aspartate protected the cysteine introduced at glycine 62 (located in the periplasmic water-filled 
pore) against reaction with OGM. In contrast, aspartate stimulated the reactivity the cysteine 
introduced at proline 79 (located in the cytoplasmic water-filled pore) with OGM. These results 
demonstrate that TM3 underwent aspartate-induced conformational alterations.  
 
 
INTRODUCTION 
In some strains of the lactic acid bacterium Tetragenococcus halophilus, a proton-motive 
force (PMF) is generated by the combined action of an intracellular L-aspartate decarboxylation 
reaction catalyzed by an L-aspartate--decarboxylase (AspD) and an electrogenic 
aspartate
1-
:alanine
0
 exchange reaction catalyzed by an aspartate:alanine antiporter (AspT, TC# 
2.A.81.1.1). The PMF generated is sufficiently high to drive ATP synthesis via the bacterial F0F1 
ATPase. This combination of PMF and ATP synthesis has been proposed as a proton-motive 
metabolic cycle, and the prototype model is found in Oxalobacter formigenes (Abe et al., 
1996b; Anantharam et al., 1989; Maloney et al., 1994). In previous works using 
proteoliposomes, we found that the aspartate:alanine exchange catalyzed by AspT is 
electrogenic (Abe et al., 1996a; Abe et al., 2002). The biochemical features of substrate 
transport by AspT indicate that the protein can be classified as a conventional secondary 
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transport protein and that it is an electrogenic antiporter similar to the prototype 
precursor:product exchanger OxlT, an oxalate:formate antiporter that is a member of the major 
facilitator superfamily, from O. formigenes (Anantharam et al., 1989; Ruan et al., 1992; 
Maloney et al., 1994; Abe et al., 1996b). AspT belongs to the newly classified aspartate:alanine 
exchanger (AAE) family (TC# 2.A.81) of transporters in the transporter classification system 
developed by Milton H. Saier Jr. et al. (http://www.tcdb.org/index.php). Recently, the results of 
a BLAST (http://www.ncbi.nlm.nih.gov/BLAST/; Altschul et al., 1990) search of the nucleotide 
sequence of the aspT gene and the amino acid sequence of the AspT protein against current 
nucleotide and protein databases have suggested that AAE family transporters are conserved in 
many bacterial species (Barabote et al., 2006; Fujiki et al., 2007). The putative broad 
distribution of AspT orthologues and paralogues in bacteria suggests that additional biochemical 
study of AspT can be a valuable part of the ongoing investigation of membrane transport.  
AspT is an integral membrane protein containing 543 amino acids (57.2 kDa). The membrane 
topology of AspT has been studied by means of alkaline phosphatase and -lactamase fusion 
methods; it has also been studied by the substituted-cysteine accessibility method (SCAM), 
which uses the impermeant, fluorescent thiol-specific probe Oregon Green 488 maleimide 
(OGM) and the impermeant, nonfluorescent thiol-specific probe 
[2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET) (Nanatani et al., 2005; 
Nanatani et al., 2007). The topology analyses revealed that AspT has a unique topology; the 
protein has 10 transmembrane helices (TMs), a large hydrophilic cytoplasmic loop (about 180 
amino acids) between TM5 and TM6, and N- and C-termini that face the periplasm. TM3 
contains amino acid residues that are well conserved in the members of the AAE family. 
Moreover, our topology analysis indicated that there is probably an isolated charged residue 
(arginine 76) in the middle of TM3. For transporters of polar molecules such as aspartate, the 
substrate-transport pathway can be expected to be enriched with residues that are more 
hydrophilic than residues found elsewhere in the TMs.  
We applied SCAM to TM3 of AspT to further elucidate the role of TM3 in the transport 
process. Analysis of the effects of the amino acid substitutions on transporter function identified 
amino acids that are crucial for transport. Furthermore, our SCAM results suggest that TM3 
participates in the formation of a hydrophilic cleft or half-channel in the membrane and 
implicate the TM in ligand-induced conformational alterations. In addition, nonreducing 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analyses of purified AspT 
showed that some single-cysteine variants form S-S linked homo-dimers in membranes. We 
speculated that AspT forms oligomers in the membrane and that the TM3s are located very close 
to each other as shown in the similar case of the multidrug exporter AcrB of which an 
extramembrane central pore α-helix of each protomer AcrB is close to each other in the trimer 
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formation (Murakami et al., 2004). To confirm the oligomerization of AspT, we developed a 
solubilization and purification scheme under n-dodecyl--D-maltoside (DDM)–solubilized 
conditions and studied the oligomerization of AspT by means of analytical size-exclusion 
high-performance liquid chromatography (HPLC) and a glutaraldehyde cross-linking assay. 
 
 
MATERIALS AND METHODS 
Chemicals, cells, and expression plasmids 
L-[2,3-
3
H]Aspartic acid (1.07 GBq/mmol) was purchased from Amersham-Pharmacia Biotech 
(Piscataway, USA). 1-O-n-Octyl--D-glucopyranoside (OG) and DDM were obtained from 
Nacalai Tesque (Kyoto, Japan). Escherichia coli phospholipid was provided by Avanti Polar 
Lipids (Alabaster, USA) (Ambudkar and Maloney, 1986). Oregon Green 488 maleimide (OGM) 
was purchased from Invitrogen Co. (Carlsbad, USA), and 
[2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET) was purchased from 
Toronto Research Chemicals (Toronto, Canada). Escherichia coli strain XL1 blue harboring 
pMS421 (Spec
r
 LacI
q
)—referred to as strain XL3 (Abe et al., 1996b)—was used for expression 
of the asp operon with pTrc99A (Amersham-Pharmacia Biotech). 
Site-directed mutagenesis 
Single-cysteine variants were constructed by the oligodeoxyribonucleotide-directed dual 
amber mutagenesis method (Takara Bio, Tokyo, Japan; Hashimoto-Gotoh et al., 1995). The pKF 
19k/18k vector (Takara Bio) harboring the gene for cysteine-less AspT-(His)6 was used as a 
DNA template for the mutagenesis method. DNA fragments encoding AspT in which a single 
cysteine had been introduced were ligated back into the corresponding site of pBlue 
cysteine-less AspHis. DNA fragments encoding single-cysteine AspT-(His)6 were cloned into 
pTrcAsp instead of into wild-type AspT. The DNA sequences of all mutagenized AspT proteins 
were verified by DNA sequencing, as described previously (Abe et al., 2002). 
Production of single-cysteine AspT-(His)6 
A preculture of E. coli XL3 carrying pTrc single-cysteine AspT-His was diluted 100-fold in 
fresh Luria-Bertani (LB) medium containing 30 mM D-glucose, 30 g/ml carbenicillin, and 30 
g/ml spectinomycin. These cells were grown for 2.5 h at 37 °C with shaking and were then 
diluted 2-fold in fresh Luria broth containing 30 mM D-glucose, 60 mM L-aspartate, and 1 mM 
pyridoxal 5'-phosphate. The cell suspension was incubated statically for 13 h at 37 °C. Twelve 
hours before cell harvest, 200 M (final concentration) isopropyl--D-thiogalactoside was 
added to the cultures. 
Preparation of membrane ghosts and solubilization and reconstitution of AspT 
Membrane ghosts were prepared by an osmotic shock procedure (Ambudkar and Maloney, 
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1986). Harvested cells were suspended in 5 ml of a lysis solution (500 g/ml lysozyme 
[Seikagaku Co., Tokyo, Japan], 40 g/ml DNase I [Sigma, St. Louis, USA], 10 mM 
2-amino-2-hydroxymethylpropane-1,3-diol (Tris)-HCl [pH 7.5], 1 mM phenylmethyl sulfonyl 
fluoride [PMSF])] and incubated at 37 °C for 30 min. Cells were disrupted by 10-fold dilution 
in 45 ml of iced distilled water. After cell disruption, the released cytoplasmic proteins were 
removed by two cycles of centrifugation and washing with iced distilled water (Varadhachary 
and Maloney, 1990). Membrane ghosts were solubilized (Ambudkar and Maloney, 1986) using 
1.25% (w/v) OG in the presence of 0.4% (w/v) E. coli phospholipid, 100 mM KH2PO4 (pH 7), 
and 20% glycerol. Control extracts were prepared in the same way, but without added protein. 
These solubilized membrane proteins were reconstituted in a final volume of 1 ml with 800 l 
of detergent extracts (1.2 mg of protein) (or control lipid extract), 130 l of bath-sonicated 
liposomes (5.9 mg of E. coli phospholipid), and 18 l of 15% OG, with the balance made up by 
100 mM KH2PO4 (pH 7). After incubation of the mixture for 20 min on ice, proteoliposomes (or 
control liposomes) were formed at room temperature (R.T.) by rapid injection into 20 ml of a 
loading buffer containing 100 mM KH2PO4 (pH 7) and 100 mM L-aspartate as the potassium 
salt. The substrate-loaded proteoliposomes (or liposomes) were kept at R.T. for 20 min. 
Assay of aspartate transport 
Unless otherwise noted, initial rates of L-[2,3-
3
H]aspartate incorporation were measured in 
duplicate at 25 °C by means of a filtration assay (Wang et al., 2006; Ye and Maloney, 2002). 
Proteoliposomes were applied directly to the center of a 0.22-m pore-size GSTF Millipore 
filter (Millipore Co., Billerica, USA) and washed twice with 5 ml of chilled assay buffer (100 
mM KH2PO4 [pH 7], 100 mM K2SO4). Upon release of the vacuum, proteoliposomes were 
covered with pre-incubated assay buffer containing 0.1 mM L-[2,3-
3
H]aspartate, and the 
reaction was terminated after 1 min by filtration and washing. AspT function is usually reported 
as relative specific activity by normalization of observed rates to levels of AspT production as 
determined by immunoblot analysis (described below). 
Immunoblot analysis 
Detergent extracts of membrane ghosts of each of the single-cysteine variants and the 
cysteine-less parent were analyzed by SDS-PAGE. For SDS-PAGE, 45 g of proteins was used, 
and after electrophoresis the proteins were transferred to a polyvinylidene difluoride membrane 
(Nippon Genetics, Tokyo, Japan) by semidry electrophoretic blotting (Bio-Rad Laboratories, 
Hercules, USA) and probed with an anti-AspT rabbit polyclonal antibody, which was prepared 
by Operon Biotechnologies (Tokyo, Japan) using synthetic polypeptides 
(SKLPISDHLKTLYSNQ and NDVSERVGSDASPF) as antigens. AspT production was 
detected by chemiluminescence with a LAS-3000 imaging system (Fujifilm, Tokyo, Japan), and 
signals were quantified with NIH Image software (v. 1.63). Antisera were used at the following 
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dilutions: anti-AspT rabbit polyclonal, 1:2000; anti-rabbit immunoglobulin G goat polyclonal 
antibody horseradish peroxidase-conjugate (StressGen Bio. Co., Victoria, Canada), 1:2000. 
Production of each AspT variant was normalized to that of the cysteine-less parental control 
found on the same gel. 
Site-directed fluorescence labeling 
Exposure of TM3 positions to the aqueous medium was assessed in single-cysteine variants. 
Membrane pellets (prepared as above) were resuspended in 20 mM potassium phosphate (pH 8) 
or 20 mM potassium phosphate (pH 8) including 100 mM L-aspartate and incubated for 20 min 
at 25 °C with 40 M OGM, an impermeable thiol-active agent (Ye et al., 2001). The reaction 
was quenched by the addition of 6 mM -mercaptoethanol and three cycles of washing with 
distilled water. Protein was solubilized by resuspending the membrane vesicles in 1 ml of 
solubilization buffer (50 mM Tris-HCl [pH 7], 0.75 mM PMSF, 1% Triton X-100, 0.1% SDS). 
After incubation of the mixture at 4 °C for 2 h on a rotary platform shaker, insoluble debris was 
removed by centrifugation at 4 °C (17,500  g for 30 min), and AspT was purified in a one-step 
affinity procedure (Fu and Maloney, 1997; Nanatani et al., 2007). In brief, 6x histidine-tagged 
AspT was precipitated with 50 l of Ni-NTA Superflow resin (Qiagen, Valencia, CA, USA) by 
overnight batch incubation at 4 °C on a rotary platform shaker. The resin, with bound AspT, was 
washed on ice with a total of 3 ml of wash buffer (solubilization buffer supplemented with 200 
mM sodium fluoride and 25 mM imidazole). AspT was eluted by a brief centrifugation at 4 °C 
with 60 l of elution buffer (50 mM Tris-HCl [pH 7], 2% SDS, 0.5 M imidazole).  
Detection of OGM labeled protein 
Protein was subjected to SDS-PAGE with a 10% polyacrylamide gel matrix. For SDS-PAGE, 
10 l of elution sample was used, and after electrophoresis, the gel was rinsed briefly with a 
destaining solution (10% glacial acetic acid, 15% methanol). Fluorescence profiles were 
recorded with a LAS-3000 imaging system. After the fluorescence profiles were recorded, the 
protein content of each lane was evaluated by staining the same gel with Coomassie Brilliant 
Blue. 
Expression, solubilization, and purification of AspT-His under DDM solubilized conditions 
for analysis of oligomerization 
A preculture of E. coli XL3 carrying pTrc AspT-His was diluted 100-fold in fresh LB medium 
containing 30 mM D-glucose, 30 g/ml carbenicillin, and 30 g/ml spectinomycin. These cells 
were grown for 2.5 h at 37 °C with shaking and were then diluted 2-fold in fresh Luria broth 
containing 30 mM D-glucose, 60 mM L-aspartate, and 1 mM pyridoxal 5'-phosphate. The cell 
suspension was incubated statically for 13 h at 37 °C. Twelve hours before cell harvest, 200 M 
isopropyl--D-thiogalactoside was added to each culture. Membrane ghosts were prepared by an 
osmotic shock procedure (Ambudkar and Maloney, 1986). The cells harvested from each liter of 
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culture solution were suspended in 7.5 ml of a lysis solution (500 g/ml lysozyme [Seikagaku 
Co., Tokyo, Japan], 40 g/ml DNase I [Sigma, St. Louis, USA], 10 mM Tris-HCl [pH 7.5], 
1 mM PMSF)] and incubated at 37 °C for 30 min. Cells were disrupted by 10-fold dilution into 
45 ml of iced distilled water. After cell disruption, the cytoplasmic proteins released were 
removed by two cycles of centrifugation and washing with iced distilled water (Varadhachary 
and Maloney, 1990). Membrane ghosts were solubilized (Ambudkar and Maloney, 1986) at 4 °C 
for 6 h with 1.5% (w/v) DDM in the presence of 200 mM aspartate, 100 mM KH2PO4 (pH 7), 
and 20% glycerol. After centrifugation at 12,000
 
x g for 60 min, the supernatant was incubated 
with a Ni-NTA
 
affinity column (375 l bed volume for a 1-liter culture) at 4 °C for 6 h. The 
column was washed on ice with a total of 7.5 ml/1-liter culture of wash buffer (WB, 200 mM 
aspartate and 20 mM KH2PO4 [pH 7], 20% glycerol,
 
0.02% DDM, and 25 mM imidazole). Then, 
AspT was eluted by a brief centrifugation in the cold with elution buffer (200 mM aspartate, and 
20 mM KH2PO4 [pH 7], 20% glycerol,
 
0.02% DDM, and 0.5 M imidazole) at 375 l/1-liter 
culture. 
Reconstitution and transport assay of purified AspT 
The solubilized membrane proteins were reconstituted in a final volume of 1 ml with 800 l 
of detergent extracts (10 g of protein) (or control lipid extract), 130 l of bath-sonicated 
liposomes (5.9 mg of E. coli phospholipid), and 18 l of 15% OG, with the balance made up by 
100 mM KH2PO4 (pH 7). After incubation for 20 min on ice, proteoliposomes (or control 
liposomes) were formed at R.T. by rapid injection of the mixtures into 20 ml of a loading buffer 
containing 100 mM KH2PO4 (pH 7) and 100 mM L-aspartate as the potassium salt. The 
substrate-loaded proteoliposomes (or liposomes) were kept at R.T. for 20 min. To assay for 
aspartate transport by L-[2,3-
3
H]aspartate-loaded particles, proteoliposomes were diluted 
20-fold from the concentrated stock preparation into an appropriate volume of assay buffer (100 
mM KH2PO4 (pH 7) and 100 mM K2SO4). After 1–3 min of pre-incubation at 25 °C, 
L-[2,3-
3
H]aspartate was added to a final concentration of 100 M; at various times, 50- to 
100-l aliquots were removed for membrane filtration (0.22-m pore-size GSTF Millipore 
filters). The membrane filters were followed by two washes with 5 ml of assay buffer 
(Ambudkar and Maloney, 1986). 
Size-exclusion chromatography 
The purified AspT-His was loaded into
 
a Centri-Spin20 desalting column (Princeton 
Separations, Adelphia, USA) to
 
remove the imidazole used for elution. Unless noted otherwise, 
the
 
column was prehydrated with 0.6 ml of WB (without imidazole),
 
and residual buffer was 
removed by a 2-min centrifugation at 750
 
× g. Imidazole-eluted AspT-His (50 µl) was placed on 
the column, and
 
the desalted product was collected by a second centrifugation. Concentrated 
AspT (typically 10 mg/ml) was injected onto a TSK-GEL SuperSW2000 column (TosoHaas, 
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Montgomeryville,
 
USA) pre-equilibrated with a degassed mobile phase (20 mM K-Pi [pH 7], 
20% glycerol, 200 mM aspartate as the potassium salt [pH 7], 0.05% DDM).
 
The column was 
eluted with the same buffer at a flow rate of 0.2 ml/min. Elution of the proteins from the column 
was detected at a wavelength of 280 nm with an on-line UV monitor. 
Glutaraldehyde cross-linking 
Aliquots (5–10 µg) of the purified AspT-His (0.01 mg/ml in WB containing either 0.02% 
DDM or 0.5% SDS,
 
for cross-linking in native or denaturing conditions, respectively) was 
subjected to in vitro cross-linking by incubation with 0.02–0.5 mM glutaraldehyde at 25 °C for 
30 min. The reaction was terminated by the addition of gel sample buffer containing 4% SDS 
and 125 mM Tris-HCl (pH 6.8), and the samples were analyzed by SDS-PAGE with 10% 
-mercaptoethanol. The proteins were visualized by silver staining. 
 
 
RESULTS 
Transport activities of single-cysteine variants of TM3 in a functional AspT 
We performed a multiple alignment of ten AAE family transporters to identify conserved 
amino acids in the AspT proteins. The alignment showed that TM3 has many amino acid 
residues that are conserved among members of the AAE family (Fig. 1). To clarify the role of 
TM3 in aspartate transport, we performed a complete cysteine-scanning mutagenesis of TM3. In 
the first step, each amino acid of TM3 (threonine 59 to phenylalanine 88) was individually 
replaced with cysteine in a functional AspT molecule devoid of all three native cysteine residues 
(AspT cysteine-less). Active transport was measured by using L-aspartate-loaded 
proteoliposomes in which each variant of AspT was reconstituted. The most severe negative 
effects on transport were observed upon replacement of amino acids in the C-terminal 
(cytoplasmic) half of TM3 (methionine 70 to serine 84) (Fig. 2). In contrast, replacement of 
amino acids in the N-terminal (periplasmic) half of TM3 (threonine 59 to phenylalanine 69) had 
little or no effect on AspT function. The replacements of tyrosine 75 and serine 84 had the 
strongest effects on transport (initial rates of aspartate transport were below 10% of that of 
cysteine-less AspT) (Fig. 2). Considerable but less marked effects were observed upon 
replacements of glycine 74, arginine 76, and serine 83 (initial rates between 10% and 30% of 
that of cysteine-less AspT).  
Definition of the inaccessible core region of TM3 
To obtain a comprehensive picture of the accessibility of the cysteines at the various positions 
of TM3, we employed a labeling approach specific for each artificially introduced cysteine. 
Randomly oriented membrane vesicles containing the corresponding single-cysteine AspT 
variants were labeled with the hydrophilic fluorescent probe OGM. Studies of OxlT have shown 
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that cysteine residues exposed to the aqueous phase can be identified by their accessibility to 
OGM (Fu and Maloney, 1998; Ye et al., 2001; Ye and Maloney, 2002), which is known to be 
membrane impermeant under the conditions used here (Ye et al., 2001; Nanatani et al., 2007). 
After vesicle labeling, the AspT variants were solubilized from the membranes, purified by 
Ni-NTA affinity chromatography, and subjected to SDS-PAGE. The fluorescence of each AspT 
variant labeled with OGM was detected by UV irradiation of the gels (Fig. 3A, bottom panel). 
Despite the fact that amino acids threonine 59 to methionine 85 are believed to form a 
membrane-spanning domain (TM3) (Nanatani et al., 2007), cysteines placed at several positions 
within this region were modified by OGM (Fig. 3A, bottom panel). In general, positions in the 
C-terminal (cytoplasmic) half of TM3 showed higher accessibility than positions in the 
N-terminal (periplasmic) half of the TM. Introduced cysteine residues corresponding to the 
positions of glycine 62, aspartic acid 63, glycine 78, serine 80, and serine 83 were particularly 
accessible to OGM (Fig. 3A, bottom panel). This region of the protein must therefore be 
exposed to the aqueous environment. Except for aspartic acid 63 and glycine 78, all the residues 
are located on one face of the putative -helix and might be involved in the formation of a 
water-filled cavity or half-channel in the membrane (Fig. 4B). Intermediate accessibility was 
observed for the cystine residues introduced in place of leucine 61, arginine 76, proline 79, and 
methionine 85 (Fig. 3A, bottom panel). A negative response was found for the 12 cysteines at 
the center of TM3 (from isoleucine 64 to tyrosine 75).  
Influence of ligand binding on cysteine accessibility 
To further explore the role of TM3 in AspT function, we examined the influence of a native 
ligand (L-aspartate) on the accessibility of single-cysteine variants to OGM. Randomly oriented 
membrane vesicles containing the single-cysteine AspT variants were labeled after incubation 
with 100 mM aspartate. Subsequently, the AspT variants were isolated, and fluorescence was 
detected as described above (Fig. 3B, bottom panel). The analysis revealed four groups of 
single-cysteine AspT variants with the following characteristics (Fig. 3A, B, bottom panels). (a) 
Cysteines in place of leucine 61, aspartic acid 63, arginine 76, glycine 78, serine 80, serine 83, 
or methionine 85 were highly accessible to OGM, and the labeling reaction was not markedly 
influenced by the presence of aspartate. (b) Cysteines introduced at threonine 59, at leucine 61, 
from isoleucine 64 to tyrosine 75, or at valine 77, phenylalanine 81, isoleucine 82, or serine 84 
showed only low reactivity toward OGM, and the addition of aspartate did not stimulate 
cysteine reactivity. (c) The cysteine residue introduced at glycine 62 was labeled by OGM, and 
the labeling reaction was inhibited by aspartate. (d) Aspartate stimulated the reactivity of 
cysteine at position proline 79. The observed substrate protection can be explained by direct 
steric hindrance, by ligand-induced conformational alterations, which either bury the 
corresponding residue within the protein or move it from an aqueous environment into an apolar 
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environment, or by both steric hindrance and conformational alterations. 
Activity and formation of homo-dimers of purified AspT 
Nonreducing SDS-PAGE analysis indicated that some of the single-cysteine variants formed 
S-S linked homo-dimers in the membrane (Fig. 3A, top panel). This result suggests that AspT 
forms homo-oligomers in the membrane and that the TM3s of the individual protomers are very 
close to each other. To elucidate the quaternary structure of AspT by means of analytical 
size-exclusion HPLC analysis and a glutaraldehyde cross-linking assay, we developed a 
solubilization and purification scheme under n-dodecyl--D-maltoside (DDM) solubilized 
conditions. 
An AspT variant with a six-histidine tag inserted into the large hydrophilic loop (Nanatani et 
al., 2007) was expressed
 
in E. coli, solubilized in detergent (DDM), and purified by a
 
conventional one-step procedure involving Ni-NTA chromatography (Fig. 5A).
 
We observed a 
single band on SDS-PAGE at a position lower than that expected from the polypeptide sequence 
(58.0
 
kDa) of the AspT variant; similar results have been observed for other membrane proteins 
(Abe et al., 1996b). Then we reconstituted the purified AspT variant into proteoliposomes and
 
confirmed that it catalyzed aspartate self-exchange and electrogenic aspartate:alanine exchange 
reactions. The proteoliposomes containing the purified AspT variant were loaded with 100 mM 
potassium aspartate. Then the proteolipsomes were resuspended in 0.1
 
M potassium phosphate 
buffer (pH 7), and aspartate exchange reactions were started by addition of 
 
100 µM (final 
concentration) external [
3
H]aspartate. [
3
H]aspartate
 
was incorporated into proteoliposomes by 
aspartate self-exchange. The steady-state
 
incorporation of [
3
H]aspartate was approximately 3300 
nmol/mg
 
of protein (Fig. 5B). Moreover, accumulated [
3
H]aspartate was released by the addition 
of excess unlabeled aspartate
 
or alanine, suggesting that we succeeded in purifying the AspT 
while completely maintaining its transport activity. 
  Analytical
 
size-exclusion HPLC analysis indicated that the purified AspT
 
was free of 
high-molecular-weight aggregates, showing a major
 
monodisperse species with a retention
 
time 
corresponding to an apparent molecular mass of 204 kDa (Fig. 6A). This result indicated that 
AspT was purified as
 
a single oligomeric species; however, the order of AspT oligomerization is 
yet to be determined. To evaluate the oligomeric
 
state of the protein, we carried out 
glutaraldehyde cross-linking. Directed
 
at surface-exposed amino groups, glutaraldehyde has 
been used
 
to analyze the quaternary structures of purified multisubunit
 
membrane proteins (Roth 
et al., 1980; Lai et al., 1989; Sakaguchi et al., 1997; Maduke et al., 1999; Yernool et al., 2003). 
Treatment of purified AspT protein with glutaraldehyde showed shifts of the
 
monomer band (at 
~50-kDa on a denaturing SDS gel) to
 
position (100 kDa) expected for homo-dimers (Fig. 6B). 
Moreover, cross-linker treatment in a denaturing
 
detergent (SDS) failed to shift the monomer 
band. This result supports the idea that the band shifts were caused by
 
intermolecular 
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cross-linking. The
 
glutaraldehyde-treated samples, whether cross-linked or not,
 
ran as fuzzy 
bands, as expected from the adduct heterogeneity
 
derived from the different extents of 
glutaraldehyde-modification in the individual monomers and dimers by this reaction. The results 
of analytical size-exclusion HPLC analysis and the glutaraldehyde cross-linking assay suggest 
that functional AspT formed homo-dimers under the DDM solubilized conditions. 
 
 
DISCUSSION 
Identification of sites involved in both substrate binding and translocation is a central goal of 
ongoing studies of AAE family transporters. Solute transporters such as AspT and OxlT have a 
network of key amino acid residues that facilitate substrate movement into and out of an 
appropriate binding site, thereby defining a substrate-translocation pathway through the protein 
(Yan and Maloney, 1993; Yan and Maloney, 1995). For transporters of polar molecules such as 
aspartate, this pathway is assumed to be enriched in residues of a more hydrophilic character 
than found elsewhere in the transmembrane helices like substrate translocation pathways found 
in other transporters (Maloney, 1990; Goswitz and Brooker, 1995; Yan and Maloney, 1995; 
Doyle et al., 1998; Kaback, 1998). For these reasons, because TM3 is enriched with hydrophilic 
amino acid residues including arginine 76 that is the only charged residue in the AspT 
hydrophobic sector, TM3 deserves attention.  If so, residues on the same helical face as 
arginine 76 might also be expected to be involved in the substrate-translocation pathway. To 
investigate the role of TM3, we performed a complete cysteine-scanning mutagenesis study of 
TM3 in the presence and absence of aspartate to learn more about the membrane topology, 
possible ligand-binding sites, and functional dynamics of AspT. 
Assignment of TM3 to the translocation pathway 
  Cysteine scanning of TM3 revealed that alteration of 5 of the 27 amino acid positions tested 
markedly reduced AspT function. The results indicated that glycine 74, tyrosine 75, arginine 76, 
serine 83, and serine 84 play crucial roles in AspT function. Glycine 74 is conserved within the 
AAE family (Fig. 1). Although tyrosine 75 and serine 84 are well conserved (but not 
completely) within the family, an aromatic amino acid (tyrosine or phenylalanine) and a small 
amino acid (serine, glycine, or alanine), respectively, are found at those positions in other 
members of this family. Substitution of serine 83 with cysteine may cause local structural 
perturbations affecting the adjacent functionally important region around serine 84, thereby 
explaining the reduced transport activities of the corresponding mutants. Arginine 76 of TM3 is 
not conserved within the AAE family, but a charged or polar amino acid is found at this position 
in other members of the family (Fig. 1). Therefore, we speculated that arginine 76 is located on 
the hydrophilic face of TM3, which was supported by the fact that this residue was accessible to 
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sulfhydryl reagents (Fig. 3) (see also discussion below). Glycine 74 may be important for the 
structure or conformational flexibility of TM3. A similar role has been reported for specific 
glycine residues in LacY of E. coli (Jung et al., 1995; Weinglass and Kaback, 1999; Abramson 
et al., 2003). In fact, our results indicate that TM3 of AspT is involved in ligand-induced 
conformational alterations, as described below. Taken together, the results of the activity 
measurements confirmed the particular functional significance of TM3 in the transport process.  
To obtain a comprehensive picture of the accessibility of cysteines at the various positions of 
TM3, randomly oriented membrane vesicles containing single-cysteine AspT variants were 
labeled with the hydrophilic fluorescent probe OGM. The labeling experiments (Fig. 3) revealed 
a striking discontinuity in OGM accessibility along TM3. Thus, when AspT was labeled in situ, 
OGM failed to react with cysteines within a central 12-residue segment (residues 64–75), 
whereas cysteines at either end of this segment yielded fluorescent products (Fig. 3). These 
results indicate that residues 64–75 form the hydrophobic core of TM3. There are two possible 
general explanations for such findings. The first possibility is that the region of low OGM 
reactivity (positions 64–75) is within the lipid bilayer and hence inaccessible to the impermeant 
probe. Once OGM has modified its target, the OGM carboxylate lies about 8–10 Å from the 
target cysteinyl sulfur; therefore, cysteines that react with OGM can be expected to be within 
8–10 Å of the external or internal aqueous phase. If TM3 forms a transmembrane α-helix with 
20–25 residues that span the 30–40-Å bilayer, a central core of some 10 residues (e.g., residues 
64–75) can be expected to be inaccessible to OGM for purely geometric reasons. The second 
possible explanation is that cysteines in this core are unreactive for some reason having to do 
with their chemical environment. Cysteines in a nonpolar (i.e., lipid) environment are generally 
thought to have high pKa values (pKa = 14) characteristic of the side chain of cysteine (Fu and 
Maloney, 1998). In the second explanation, the reactive sulfide (–S1-) would not be present at a 
sufficiently high concentration to permit its chemical modification with OGM. We caution, 
however, that these two explanations are not mutually exclusive. A transmembrane helix might 
have positions that face other helices or the hydrophilic translocation pathway (e.g. Goswitz and 
Brooker, 1995); these positions might be inaccessible but chemically reactive. In contrast, there 
might be positions that face membrane lipid, and these positions might be accessible but 
chemically unreactive. 
In addition, it is noteworthy that most positions (7 in 10 residues [arginine 76 – methionine 
85) located in the cytoplasmic half of TM3 showed the highest reactivity to OGM. Taken 
together, the data suggest that the polar face of the putative -helix is exposed to an aqueous 
cavity that is open to the cytoplasmic side of the membrane. This cavity most likely extends 
from the cytoplasmic end of TM3 to the middle of the domain (residues 76 to 85) (Fig. 4). The 
OGM labeling profile of arginine 76 to methionine 85 suggests that AspT has an ―inward 
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opening‖ structure. Of the two residues identified earlier as important to TM3 function, tyrosine 
75 lies at the cytoplasmic border of the core domain, whereas serine 84 lies at the cytoplasmic 
cavity. The existence of a hydrophilic cleft within the membrane has recently also been reported, 
for example, for the OxlT and the glycerol 3-phosphate transporter GlpT of E. coli (Fu and 
Maloney, 1998; Ye and Maloney, 2002).  
Although most of the inaccessible residues cluster on the face of TM3 that is located opposite 
to the easily accessible positions at leucine 61, glycine 62, arginine 76, proline 79, serine 80, 
and serine 83, there are some exceptions (Fig. 4). For example, aspartic acid 63 and glycine 78 
are located on a face of low accessibility but were nevertheless labeled to a large extent with 
OGM. In contrast, cysteines that replaced phenylalanine 65, phenylalanine 69, or alanine 72 are 
located on a highly accessible face but showed little or no accessibility to OGM. This 
inconsistency may be explained by the hypothesis that TM3 of AspT does not form a regular 
-helix that spans straight across the membrane. In fact, TM3 contains a proline residue 
(position 79) and glycine residues (positions 62, 74, and 78) that may be involved in the 
formation of kinks and bends, thereby distorting the regular -helical structure. This possibility 
is consistent with the crystal structure of LacY in which only 3 of 12 helices appear to be 
straight; all the others are arched, kinked, or S-shaped (Abramson et al., 2003). 
Aspartate-induced conformational alteration 
In TM3 there are a number of positions that show intermediate accessibility to OGM (Fig. 3A, 
B bottom panels, and Fig. 4, residues in gray circles). In agreement with the proposed 
distinctive nature of TM3, the intermediate accessibility to OGM may be due to conformational 
flexibility of the domain; this flexibility may facilitate trapping of individual positions by 
sulfhydryl reagents. This phenomenon has been explained by an aspartate-induced 
conformational alteration that makes these positions accessible to the aqueous phase and leads 
to aspartate binding at, or close to, these residues.  
In the case of the cysteine at position 79, which is in a cytoplasmic cavity, the reactivity of 
cysteine was markedly stimulated in the presence of aspartate. Although the presence of 
aspartate inhibited the reactivity of the cysteine at position 62, which is in a periplasmic 
water-filled pore, the position 62 exhibited high accessibility to OGM in the absence of 
aspartate (Fig. 3, lanes 5 and 22). The aspartate-dependent protection of G62C against OGM 
labeling may be achieved by direct steric hindrance derived from aspartate-binding to the 
positions close to G62, but this reason does not explain the stimulatory effect of aspartate on 
OGM labeling at P79C. A second possibility is that there may be an aspartate-induced 
conformational alteration that buries or exposes the residues within the protein.  For an 
example of substrate-induced conformational alteration, fourier transform infrared spectroscopy 
and hydrogen-deuterium exchange experiments on the Na
+
/melibiose transporter MelB of E. 
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coli revealed that substrate binding reduces the accessibility of water to the protein backbone 
and increases the compactness of the transporter structure (Dave et al., 2000; le Coutre et al., 
2002). 
Dimerization of AspT 
Analytical size-exclusion HPLC analysis and a glutaraldehyde cross-linking assay suggest 
that functional AspT formed homo-dimers under DDM solubilized conditions (Fig. 6A, B). In 
addition, in cysteine-scanning mutagenesis experiments, some single-cysteine variants of TM3 
formed S-S cross-linked homo-dimers in the membrane. These results suggest that TM3s in 
individual protomers were very close to each other in the homo-dimer of AspT. In many 
membrane proteins, the GxxxG motif (two glycine residues separated by any three residues) is 
often found to be important for mediating the interaction of TM helices (Curran and Engelman, 
2003; Senes et al., 2004). Early studies on the glycophorin A TM dimer (including mutagenesis, 
computational modeling, and thermodynamic characterization) showed the central role of 
GxxxG (Lemmon et al., 1992; Adams et al., 1996; Fleming et al., 1997) for TM interaction. For 
secondary transporters, the human serotonin transporter and the osmosensor and osmoprotectant 
transporter of E. coli have recently been reported, and GxxxG motifs in their transmembrane 
helixes play an important role in their oligomerization and helix-packing (Feng and 
Chun-Cheng, 2007; Horschitz et al., 2007). In addition, recent structural studies of the 
potassium channel and Ca
2+
-ATPase revealed that the small side chains of the amino acid 
residues found in the GxxxG motifs of these proteins play an important role in the stability and 
conformational changes of the proteins during the substrate-transport process (Curran and 
Engelman, 2003). Interestingly, in the AAE family transporters, we found highly conserved 
GxxxG motifs in the hinge region (GYxxGP) that connects the N- and C- terminal halves of 
TM3 (Fig. 1), and cysteine substitutions for those amino acids of AspT decreased 
aspartate-transport activities (Fig. 2).  Moreover, we found aspartate-induced conformational 
alterations in TM3, and the most drastic alterations of the reactivity of substituted cysteine 
residues toward OGM were observed at proline 79, which is located next to the GxxxG motif 
(Fig. 3). These results imply that the GxxxG motif is involved in oligomerization and 
conformational alterations of AspT. 
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Fig. 1 Multiple sequence alignment of members of the AAE family transporters. A multiple
alignment was generated using ClustalW2 (1.83) with sequences (FASTA) obtained from a
blastp search (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) against AspT of T. halophilus
(S wi s s -P ro t en t ry Q8L3K8) a t t he EBI www-s e rve r
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) (Pearson, W.R. 1990 Mol Enz, Pearson,
W.R. 1988 PNAS). The chosen matrix was blosum, penalties were 10 (open gap), 0.05
(extending gap), and 10 (gap distance). The resulting alignment was optically improved by the
Boxshade3.31 program (http://bioweb.pasteur.fr/seqanal/interfaces/boxshade.html),
highlighting conserved residues in black (>60% identical to consensus) or gray (>60% similar
to consensus). The term AspT refers to the homology with AspT of T. halophilus, experimental
evidence for aspartate/alanine antiporter activity exists only for T. halophilus (Thal) and
Comamonas testosteroni (Ctes). Arabic numbers indicate the position in the primary sequence
and refer to the first amino acid of the alignment.
Fig. 2 Aspartate transport by TM3 single-cysteine mutants. AspT function was evaluated for a
single-cysteine panel spanning TM3 (T59C - F88C). Initial rates of [3H]aspartate transport,
normalized for levels of AspT expression, are given relative to that of the cysteine-less
parental protein, whose activity was 4.24 nmol/min/mg of protein (horizontal line).
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Fig. 3 OGM binding to single-cysteine variants of TM 3. The hydrophobic core of TM 3 was
defined experimentally by OGM labeling of the indicated single-cysteine variants spanning
the whole of the transmembrane segment. Membrane ghosts of each variant were exposed to
OGM in the absence (A) or presence (B) of aspartate, prior to protein solubilization,
purification and analysis using SDS-PAGE. A single gel containing all samples was used to
record the fluorescence signal (bottom panel) before staining with Coomassie Blue to
visualize protein (top panel).
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Fig. 4 Schematic presentation of the Cysteine accessibility and the effect of ligand binding on
the Cysteine accessibility of TM3. The figure summarizes the Cysteine accessibility data
shown in Figs. and . Residues in black circles are highly accessible to OGM; residues in gray
circles show an intermediate accessibility; residues in white circles are not or only slightly
accessible; The reactivity of cysteine at amino acid position written in gray triangle was
stimulated by aspartate; amino acid position written in black triangle was protected by
aspartate. A, side view of TM3. B, helical wheel projection of TM3.
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Fig. 5 Purification of AspT and assay of aspartate transport by using proteoliposomes containing
purified AspT-(His)6. A, SDS-PAGE analysis of purified AspT. B, Proteoliposomes loaded with
100 mM aspartate and 100 mM potassium phosphate (pH 7.0) were placed in assay buffer (100
mM potassium phosphate [pH 7], 100 mM potassium sulfate) at 10μg of protein/ml along with
100 μM [3H]aspartate. Uptake of L-[3H]aspartate by the proteoliposomes containing purified
AspT-(His)6 is shown (■). Proteoliposomes were allowed to take up L-[3H]aspartate for 7.5 min.
At the time indicated by the arrow, L-aspartate was added to achieve a final concentration of 15
mM ( ). Samples were removed, filtered, and washed at the times indicated.
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Fig. 6 Analytical size-exclusion HPLC and glutaraldehyde cross-linking of the purified AspT. A,
Plot of log molecular weight of standards versus retention (ml). The AspT-DDM complex has an
apparent molecular mass of 204 kDa, according to a calibration with the following protein
standards: OA, ovalbumin (43 kDa); CA, canalbumin (75 kDa); AL, aldolase (158 kDa); FR,
ferritin (440 kDa). B, Image of silver-stained SDS-PAGE gel of AspT after glutaraldehyde (GA,
0.05-0.5 mM) cross-linking in 0.05% DDM or 0.5% SDS.
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CHAPTER V 
 
CONCLUSION 
 
5-1 Topology analysis of AspT 
 
The topology analyses by means of PhoA-, BlaM-fusion methods and the substituted-cysteine 
accessibility method revealed that AspT has a unique topology as follows; (i) The protein has a 
ten transmembrane helices with a large hydrophilic cytoplasmic loop (about 180 amino acids) 
encompassed with TM5 and TM6, (ii) Both N and C termini face the periplasm, and (iii) A 
positively charged residue (arginine 76) is located in the middle of TM3. In other experiments, 
cysteine scanning mutagenesis revealed that the loop 4 forms a re-entrant loop in which some 
positions of cysteine substitution variants were labeled by OGM from both periplasmic and 
cytoplasmic sides (Fujiki unpublished data). In addition, a re-entrant loop prediction program 
CLAMP (Hirokawa, http://www.cbrc.jp/clamp/beta/) predicted that AspT has another re-entrant 
loop between TM9 and TM10 (loop 9). Overall, despite the lack of significant homology 
between the amino acid sequences of the N- (TM1-TM5) and C-terminal (TM6-TM10) 
transmembrane domains, the two domains are related by an approximate two-fold symmetry 
axis in the plane
 
of the membrane. In other words, the two domains are oriented antiparallel to 
each other in the membrane. Some secondary transporters have same antiparallel
 
structures, for 
example leucine transporter , LeuTAa (1), the H
+
/Cl
–
 exchange transporter, ClC (2),
 
and Na
+
/H
+
 
antiporter, NhaA (3). 
  Although the large hydrophilic cytoplasmic loop (LHC loop) is a structurally well conserved 
within the AAE family transporters, its detailed structure and function are not clear. 
InterProScan Sequence Search, a domain search program from putative amino acid 
sequences, predicted that there is a TrkA_C domain in the LHC loop. TrkA_C domain has been 
found in the bacterial TrkA protein (Swiss-Prot entry P0AGI8), a regulator protein of potassium 
transport in bacteria (4). However TrkA_C domains are broadly distributed in membrane 
transport proteins of archaebacteria, bacteria and eukaryotes, functions of these domain are not 
well defined, and speculated that the domain binds a hitherto unidentified ligand and regulates 
transport activities (5). To our knowledge, little is known about secondary transporters that have 
a transport-regulatory domain in a single polypeptide. Then, we thought that studying the 
structure and function of TrkA_C domains is worthwhile and that AspT is a good example of 
the membrane transport proteins having TrkA_C domains. 
  In this study, we produced and purified recombinant protein of the loop region (arginine 178 
to asparagine 361). The circular dichroism spectrum of the recombinant protein was analyzed, 
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and the results suggested that the recombinant protein had secondary structures such as 
-helices and -structures. Furthermore, we carried out homology modeling of the 
three-dimensional structure of the large hydrophilic loop region of AspT by means of the full 
automatic modeling system FAMS (6,7). The constructed three-dimensional structure indicates 
that the large hydrophilic cytoplasmic loop of AspT possesses a TrkA_C domain and a 
TrkA_C-like domain and that the three-dimensional structures of these domains are similar to 
each other even though their amino acid sequences show low similarity. In addition, we found a 
small gap between -helices and -sheets in each domain, and those gaps had an enough space 
to catch some ligand. However, this prediction supports the idea that TrkA_C domain is a 
regulator domain of transporters, to discuss the function of the TrkA_C domain, more functional 
and structural studies are required. 
 
 
5-2 Analysis of Substrate transport pathway of AspT 
 
Because the TM3 has many amino acid residues conserved in AAE family and some 
hydrophilic residues, we thought that the TM3 forms a part of the translocation pathway and 
contains a binding site for substrate. In this study, to elucidate the role of the TM3 in the 
transport process, vertical cysteine-scanning mutagenesis was applied to TM3. Significant 
defects of AspT function were observed upon substitutions of tyrosine 75 and serine 84 by 
cysteine, and this result suggests that those residues play an important role in the substrate 
transport process of AspT. Then, cysteines close to the periplasmic face (residues 64–75) were 
not labeled with the large thiol reagent fluorescein maleimide, Oregon Green maleimide (OGM). 
The inaccessibility of OGM to the region (residues residues 64–75) suggests that the TM3 has a 
hydrophobic central core at periplasmic side and hydrophilic residues in the cytoplasmic half of 
TM3 participate in the formation of an aqueous cavity in the membrane. Moreover, aspartate 
protected the reaction of a cysteine at glycine 62, a residue position in periplasmic water filled 
pore, to OGM. While aspartate stimulated the reactivity of cysteine toward OGM at proline 79, 
residue position in cytoplasmic water filled pore. These results demonstrate that TM3 
participates in aspartate-induced conformational alterations. 
 
 
5-3 Substrate Transport Mechanism of AspT 
 
Secondary transporters are consisted of multiple membrane-spanning segments and the 
transporters catalyse the movement of molecules (substrates) and ions across lipid bilayer 
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membranes. Because membrane transport proteins generally show high hydrophobicity owing 
to multiple transmembrane helices and the hydrophobic sectors including the multiple 
transmembrane helices are highly flexible, there have been many difficulties in the crystal 
structure determination of transporters until the first report about crystal structure of a multidrug 
efflux transporter (AcrB)(8). So far, crystal structures of ten secondary transporters have been 
reported (Table 1). For channels and pumps (primary transporters), their crystal structures 
conserved structural similarity among each other. However, comparison of crystal structures of 
secondary transporters revealed that both their structure and transport mechanisms are in great 
diversity. Accordingly, the structural and mechanistic diversity may contribute to great variety 
of substrates and physiological functions of secondary transporters. In addition, secondary 
transporters, like many ion channels, have selective binding sites for permeant molecules and 
ions, but unlike most ion channels, transporters are believed to possess two 'gates' that can 
alternately allow access to the binding sites from either side of the membrane bilayer, as judged 
by their function. 
TM3 of AspT possess many hydrophobic amino acid residues at the periplasmic side, by 
contrast, many polar amino acids are found in the cytoplasmic side. Moreover, in this study, 
residues predominantly located in the cytoplasmic half of TM3 show the highest reactivity with 
OGM. In brief, the C-terminal half of TM3 is thought to be exposed to an aqueous cavity that is 
open to the cytoplasmic space. Taken together, these data suggest that TM3 has two regions; the 
hydrophobic core (isoleucine 64- tyrosine 75) and the hydrophilic helix (arginine 76- 
methionine 85) which forms a water filled cavity (Fig. 1). As a result, it is suspected that TM3 
may not form a regular -helix that spans the membrane in a straight form. In fact, TM3 
contains a proline (position 79) and glycine residues (positions 74 and 78) at the center, which 
may be involved in the formation of the kink and bend thereby distorting a regular -helical 
structure. Interestingly, the cysteine-substitutions for amino acid positions in the hinge region 
(GYRVGP) connecting N- and C- terminal halves of the TM3 mostly caused decreases in their 
aspartate transport activities. Moreover, an amino acid sequence GYxxGP is strongly conserved 
within the AAE family transporters. Similar kinked helices are found in the crystal structures of 
some secondary transporters, for example TM7 of Gltph, TM1 and TM6 of LueTAa, TM4 and 
TM11 of NhaA. In the crystal structure of LueTAa, residues valine 23 and glycine 24, adopt an 
extended conformation, linking segments of TM1. In the TM6 of LeuTAa, residues serine 256 to 
glycine 260 adopt extended, non-helical conformations. These two breaks in helical structure 
expose the carbonyl oxygen and nitrogen atoms in the backbone of the helical peptide bonds to  
a substrate leucine , and those atoms make most of the contacts with the -amino and -carboxy 
groups of the bound leucine. In addition, the negatively charged ends of the TM1a and TM6a 
helix dipoles are proximal to the amino group of leucine (1). 
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  While, in many membrane proteins, the GxxxG motif (two glycine residues separated by any 
three residues) are often found to be important for mediating the interaction of TM helices 
(9,10). The discovery and characterization of the GxxxG motif were, in a large part, a result of 
the work of the Engelman laboratory at Yale University. Early studies on the glycophorin A 
(GpA) TM dimer, including mutagenesis, computational modeling and thermodynamic 
characterization, showed the central role of GxxxG (11-13). For secondary transporters, recently, 
serotonin transporter (SERT) of human and osmosensor and osmoprotectant transporter (ProP) 
of Escherichia coli are reported and their GxxxG motifs in transmembrane helixes have an 
important role for their oligomerization and helix-packing (14,15). Interestingly, in cysteine 
scanning mutagenesis experiments of AspT, some single cysteine variants of TM3 formed S-S 
cross-linked homo-dimer in the membrane. This S-S linked dimerization suggests that TM3s of 
each protomer are located very close to each other in oligomerized AspT, and supports the idea 
that GxxxG motif of TM3 concerned with oligomerization of AspT. Moreover, recent structural 
studies of potassium channel and Ca
2+
-ATPase revealed that the small-sidechain residues in 
their GxxxG motifs play an important role in their stability and conformational changes during 
substrate transport process (9). For AspT, we showed aspartate-induced conformational 
alterations at TM3 in this study. The most drastic changing of the reactivity of substituted 
cysteine residues toward OGM were observed at proline 79 which locates next to the GxxxG 
motif. This result implies that the GxxxG motif also plays an important role in conformational 
alterations of AspT. 
  Tyrosine 75 located in GxxxG motif is mostly conserved within the AAE family transporters. 
Moreover, the substitution of tyrosine 75 of AspT TM3 to cysteine significantly lost its 
transport activity (CHAPTER IV, Fig. 2). X-ray analysis of crystal of LueTAa revealed that the 
hydroxyl group in the side chain of the tyrosine 108 forms a hydrogen bond with the main-chain 
amide nitrogen of leucine 25,and the interaction may function as a latch to stabilize the irregular 
structure near the unwound region in TM1. This tyrosine is strictly conserved among all the 
neurotransmitter/Na
+
 symporter (NSS) family members and has been implicated in substrate 
binding and transport in GAT1 (16), SERT (17) and GLYT2a (18). In addition, tyrosine 268 of 
LueTAa forms a cation- interaction with arginine 5 and stabilizes the conformation of 
TM1a−TM6b and anchors the amino terminus. This residue is also strictly conserved among 
other NSS family members. Therefore, we are speculating that tyrosine 75 of AspT has some 
similar roles for substrate transport to those of the tyrosine 268 of LeuTAa. 
Substitution of arginine 76 with cysteine (CHAPTER IV, Fig. 2) and other amino acid 
residues (data not shown) did not cause significant loss of transport activity, and this residue is 
not conserved within the AAE family. These results suggest that this residue is not essential for 
substrate transport. But a charged or polar amino acid could be found at this position in other 
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members of the family and this residue is accessible to sulfhydryl reagents. In addition, the 
helical wheel presentation of TM3 suggests that arginine 76 is located at the hydrophilic side of 
TM3. The function and importance of this residue remains unclear. Additional studies, for 
example kinetic analysis of arginine 76 substitution variants with other amino acids, are 
required to obtain more detail information about the function of this residue. 
  AspT has four phenylalanine residues in the TM3 hydrophobic core and these residues are 
well conserved in the AAE family transporters. For LueTAa, aromatic amino acid residues 
(phenylalanine, tyrosine and tryptophan) play important roles as a gate from cytoplasmic or 
periplasmic cavity, a zipper stabilizing the conformation with a cation- interaction, and a 
substrate binding site by means of a hydrogen-bond network. Therefore, four phenylalanine 
residues in hydrophobic core may have some similar roles in the substrate transport process of 
AspT. 
I represented the putative movement of TM3 accompanied by substrate transport in Fig. 1. 
However, other cysteine scanning experiments revealed that loop 4, which is forming a 
re-entrant loop structure, also provokes conformation changes with substrate binding (Fujiki 
unpublished data). Therefore, substrate transport may be achieved by not only TM3 but also 
other TMs and re-entrant loops. Overall, except for a large hydrophilic cytoplasmic loop, 
structural natures of AspT such as an antiparallel topology, two re-entrant loops and a GxxxG 
motif were found in the crystal structure of leucine transporter (LueTAa). Therefore, substrate 
transport mechanisms of LueTAa will give us useful ideas when we image the mechanisms of 
AspT. However, to get insight of more details about substrate transport mechanisms of AspT, it 
is necessary to promote more biochemical and crystallographic studies. 
 
 
5-4 Prospect for the future 
 
Both the continuing biochemical studies of transporters for many years and recent genome 
sequence analyses have well demonstrated that there are many kinds of transporter families in 
microbes. Primarily, the bacterial transporters play important roles for maintaining homeostasis 
of microbes.  But, we prospect that they are also important for fermentation industry, because 
transporters import raw materials (precursors) into cells and export useful biochemicals 
(fermentation products) from cells. In short, biochemicals made by microbial fermentation such 
as amino acids and nucleic acids are exported to media via several transporters. Although, since 
a discovery of Corynebacterium glutamicum in 1975, more than 1,000,000 tons of L-glutamate 
are annually produced by microbial fermentation (19), the mechanism of export process of 
L-glutamate has remained unclear for many years. In 2007, Nakamura J., et al reported an 
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exporter that was involved in the export process of L-glutamate from cells in C. glutamicum 
(20), and importance of transporter in microbial fermentation is gradually recognized by 
fermentation industry. I believe that studies of membrane transport proteins will give us a new 
technology for innovation of microbial fermentation in the near future. 
 
 
5-5 Supplemental Information; Transport Mechanisms of other Secondary Transporters 
(All sentences and figures were adapted from references.) 
 
5-5-1 LacY : Lactose Permease Transporter (Figs. 2 A and B, Kaback, H.R. 2005 Comptes. 
Rendus. Biologies., (21)) 
The mechanism of lactose/H
+
 symport can be explained by a simple kinetic scheme. Briefly, 
influx consists of six steps: starting from the outward-facing conformation (A); protonation of 
LacY (B); binding of lactose (C); a conformational change that results in the inward 
conformation (D); release of substrate (E); release of the H
+
 (F); return to the outward 
conformation. As discussed above, the structure corresponds to the protonated, inward-facing 
conformation with bound substrate. LacY in the outward-facing conformation might be very 
unstable and protonated immediately as postulated. In this state, the H
+
 is on glutamate 269 or 
shared between glutamate 269 and histidine 322. Ligand is recognized initially by tryptophan 
151, arginine 144 and glutamate 126, which may induce H
+
 transfer to histidine 322 and 
subsequently to glutamate 325 as glutamate 269 is recruited to complete the binding site by 
H-bonding to arginine 144 and tryptophan 151. This process may also trigger transition to the 
inward conformation. Substrate is then released into the cytoplasm, followed by release of the 
H
+
 from glutamate 325 due probably to a decrease in pKa caused either by approximation to 
arginine 302 or exposure to solvent in the aqueous cavity (cytoplasmic pH is ca. 7.6). Several 
lines of evidence indicate that the H
+
 is released from glutamate 325. After releasing the H
+
 
inside, transition into the outward-facing conformation is induced. The structure of LacY 
exhibits a single sugar-binding site at the apex of a hydrophilic cavity open to the cytoplasm, 
and it has been postulated that the binding site has alternating access to either side of the 
membrane during turnover. However, it is not clear whether changes binding affinity, 
particularly with LacY, where it has been shown that ΔΨ and ΔpH have quantitatively the same 
kinetic, as well as thermodynamic, effect on transport. Therefore, it seems reasonable to suggest 
that enhances the rate of deprotonation on the inner surface of the membrane, and 
thereby allows unloaded LacY to return to the outward-facing conformation more rapidly. Thus, 
the major effect of on active transport by LacY appears to be kinetic with little or no 
change in affinity for sugar. 
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5-5-2 GltPh : Glutamate Transporter (Figs. 2 C and D, Yernool, D. et al. (2004). Nature, (22)) 
The alternating access mechanism is a simple model by which to understand the activity of 
glutamate transporters. In this model an intramembranous substrate-binding site is flanked by 
two gates that allow alternating access of the substrate to either the extracellular or intracellular 
solution. Perhaps the most striking feature of the GltPh structure is the aqueous basin that allows 
for substrates and ions to access binding sites approximately halfway across the membrane, 
directly from bulk solution. Substrate-binding sites are located 5 Å beneath the basin bottom 
and are secured underneath the tips of HP2. HP2 comprises the extracellular gate. Directly 
under the binding pocket are HP1, TM7a and the C-terminal part of TM8 
, HP1 forms the intracellular gate because movement of HP1 relative to TM7 and TM8 would 
open an aqueous pathway from the substrate-binding site to the cytoplasm. Moreover, in the 
GltPh structure there are small cavities along the HP1 and TM8 interface, suggesting that 
changes in the packing of the helices are plausible. The GltPh structure represents a bound state 
of the transporter with both gates closed. Some biochemical experiments suggest that HP2 
undergoes substrate-dependent conformational changes. For example, the solvent accessibilities 
of residues in HP2 and TM7 are modulated by glutamate and sodium in eukaryotic transporters. 
Furthermore, fluorescence experiments on hEAAT3 demonstrate that the loop connecting HP2 
to TM8 undergoes changes in environment upon glutamate and sodium binding. Therefore, 
opening of the extracellular gate involves movement of the HP2 'flipper', perhaps allowing HP2 
to pack against and stabilize the TM3–TM4 loop. Even though HP1 and HP2 harbor a marked 
structural similarity that are located in different protein contexts and therefore the 
conformational changes that undergo during gating, as well as the chemical cues that activate 
gating, are probably distinct. To open the intracellular gate, HP1 moves vertically towards the 
cytoplasm and laterally into crevice 2, thereby creating a substrate transport pathway along the 
polar face of TM8 and rendering the serine-rich region of HP1 accessible to the cytoplasm. 
When the intracellular gate is open, HP2 moves towards the centre of the trimer, occupying the 
space vacated by the tip of HP1, thereby preventing the formation of an open transmembrane 
pore. Indeed, movement of HP2 is consistent with the observation that in human EAAT1 a 
cysteine introduced into HP2 forms a disulphide bond with a cysteine in TM2; the equivalent 
residues in GltPh are separated by 20 Å. Indeed, chemical modification of cysteines on the 
surface of HP2 arrests transport but not substrate binding, suggesting that HP2 may participate 
in packing interactions different from those observed in the crystal structure. Finally, the 
intracellular accessibility of the alanine 432 to cysteine mutant in GLT-1, which provided the 
basis for a proposed second re-entrant loop in glutamate transporters, is inconsistent with the 
position of HP2 in the GltPh structure because the equivalent residue, alanine 345, is located in 
the middle of HP2a and not at the tip of HP2. Movement of HP2 towards the substrate-binding 
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site could expose alanine 345 to the intracellular solution and 'seal' the transport pathway. 
 
 
5-5-3 LeuTAa: Leucine transporter (Figs. 2 E and F, Yamashita, A. et al. (2005). Nature, (1)) 
Na
+
/Cl
-
-dependent transporters are membrane-spanning proteins that catalyse the movement of 
molecules (substrates) and ions across lipid bilayer membranes. These transporters, like many 
ion channels, have selective binding sites for permeant molecules and ions, but unlike most ion 
channels, transporters are believed to possess two 'gates' that can alternately allow access to the 
binding sites from either side of the membrane bilayer, as judged by their function. The LeuTAa 
crystal structure defines the residues and protein domains that comprise the extracellular and 
intracellular gates, and it suggests conformational changes that might occur during the transport 
cycle. Access to the extracellular solution from the leucine and sodium binding sites is primarily 
obstructed by tyrosine 108 and phenylalanine 253, and layered on top of these aromatic residues 
is a conserved charged pair composed of arginine 30 and aspartate 404, which together define at 
least part of the extracellular gate. Arginine 30 and aspartate 404 interact via a pair of water 
molecules but could form a salt bridge upon rearrangement of the guanidium group. Arginine 30 
also forms a cation−  interaction with phenylalanine 253, and is ultimately connected to Na1 
via a hydrogen-bond network that includes glutamine 250. The charged pair lies at the bottom of 
the extracellular cavity, lined with small pockets and protrusions, defined by TM1b, TM3, 
TM6a, TM8, TM10 and the 'V-shaped' tip of EL4. When the extracellular gate is open, 
arginine 30 and aspartate 404 may move apart, disrupting their interaction. When the gate is 
closed, arginine 30 and aspartate 404 form a water-mediated salt link, stabilizing the 
extracellular gate in a closed conformation. In contrast to the extracellular gate, where just a few 
residues obstruct the leucine and sodium ion binding sites, the cytoplasmic gate is far more 
substantial, being composed of 20 Å of ordered protein structure. Directly beneath the 
leucine and sodium binding sites are TM1a, TM6b and TM8, with these main-chain scaffolds 
themselves blocking cytoplasmic access to the binding sites. Near the cytoplasmic face of the 
protein, another conserved charged pair, arginine 5 and aspartate 369, forms an important and 
partially buried salt bridge. Arginine 5 also forms a hydrogen bond with serine 267 and a 
cation−  interaction with tyrosine 268. Adjacent to these residues lies trptophan 8, the indole 
ring of which fits snugly in a hydrophobic pocket created by TM1a and TM6b, with its N  
nitrogen atom hydrogen bonding to the carbonyl oxygen of tyrosine 265 in TM6b. The 
conserved tryptophan 8 stabilizes the conformation of TM1a−TM6b and anchors the amino 
terminus, including arginine 5. How might the extracellular and cytoplasmic gates open? The 
architecture of LeuTAa provides tantalizing clues to possible movements of the protein backbone. 
The extracellular and cytoplasmic helical segments, that is TM1b−TM6a and TM1a−TM6b, 
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respectively, might move relative to TM3 and TM8, helping to open and close the outward and 
inward gates. Binding and unbinding of substrate and ions to the unwound joints may stabilize 
the helices in different conformational states. In calcium ATPase, for example, binding and 
release of calcium ions to unwound regions in transmembrane helices effects structural 
rearrangements. Movement in TM1 may be accompanied by a conformational change in the 
linker between TM1 and TM2, which contains the highly conserved motif NGGGAF. In 
GLYT2a and SERT, accessibility studies have revealed that this region moves during the 
transport cycle. We suggest that TM3 and TM8 may also shift their positions or rotate slightly. 
In addition, the extracellular and cytoplasmic entries could expand upon movement of 
surface-exposed elements, including the N terminus, IL1, EL2 and EL4. Indeed, construction of 
chimaeras between NET and SERT revealed that both EL2 and EL4 participate in 
conformational changes during transport. Finally, the surrounding transmembrane segments, 
TM2, TM7, TM10 and TM11, may accommodate movement of TM1, TM3, TM6 and TM8 
because they have interruptions in the middle of their helical structures caused by glycine 55 
and proline 57 in TM2, glycine 294 in TM7, glycine 408 in TM10 and proline 457 in TM11, 
most of which are conserved residues in the NSS family. 
 
 
5-5-4 NhaA : Na
+
/H
+
 antiporter (Figs. 2 G and H, Hunte, C. et al. (2005).Nature, (3)) 
The generally accepted model explaining Na
+
/H
+
 exchange and many other secondary transport 
processes is the alternating-access mechanism. In this model, the transporter has two major 
alternating conformations with the substrate-binding site facing either inwards or outwards. 
Interconversion between the two conformations in an antiporter is only possible through a 
substrate-bound form of the protein. For NhaA that means that either one Na
+
/Li
+
 or two H
+
 are 
bound. The two aspartates of the binding site are located on the straight helix V, which does not 
have conspicuous structural features for conformational changes. In contrast, the TMSs IV/XI 
assembly, with its short helices and their dipoles compensated for in the middle of the 
membrane by aspartate 133 and lysine 300, is most suitable for charge-induced subtle and fast 
conformational changes.  
At acidic pH, when it is downregulated, only part of the cation-binding site 
(aspartate 164) is exposed to the cation passage while the periplasmic passage is blocked by the 
ion-barrier formed partly by helix XIp. We suggest that at alkaline pH, in response to a signal 
from the 'pH sensor', a conformational change of helix IX results in the reorientation of helices 
XIp and IVc. This would expose the full Na
+
/Li
+
-binding site (aspartate 164, aspartate 163 and 
most probably threonine 132) to the cytoplasmic passage and remove the periplasmic ion barrier, 
leaving the extended chain to seal the binding site from the periplasm. This conformation would 
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now be ready for Na
+
/H
+
 exchange. Binding of Na
+
/Li
+
 to the active site from the cytoplasm 
would result in a charge imbalance that then would trigger a small movement of XIp and IVc 
and their extended chains. The cation-loaded binding site would thus then be exposed to the 
periplasm and sealed from the cytoplasm. On release of Na
+
/Li
+
, both aspartates would become 
protonated, thereby inducing a conformational change that would expose them back to the 
cytoplasm; deprotonation would complete the cycle. This model permits an overall 
stoichiometry of one Na
+
/Li
+
 exported in exchange for two protons taken up. Because NhaA is 
reversible, the magnitude of the electrochemical potential difference of Na
+
/Li
+
 compared with 
that of H
+
 determines the direction of the cation exchange across the membrane. The rate of 
exchange would be determined by the rate of movement of the extended chains and helices IVc 
and XIp in response to pH. Acidic pH locks NhaA, whereas alkaline pH activates it. 
This working model is strongly supported by genetic and biochemical data obtained at 
alkaline pH, at which NhaA is active. The measured Na
+
:H
+
 stoichiometry of the exchange is 
1:2. Many residues in TMS IV are conserved in the NhaA protein family, and their mutations 
markedly affect the apparent Km for Na
+
 and Li
+
. Furthermore, the need for the reorientation of 
helix IVc with respect to XIp is strongly supported by the double mutant F136C/S342C. This 
mutant forms a disulphide bond that inhibits transport, and reducing the bond restores activity in 
a reversible manner. Extensive crosslinking data are in accordance with the close contacts 
between the TMSs of the assembly and their crucial role for activity and pH regulation.  
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Table 1 Crystal Structure of Secondary Transporters
Membrane Proteins of Known 3D Structure, http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html#NewThree
Family
H+/Cl- Exchange Transporters
Multi-Drug Efflux Transporters
Major Facilitator Superfamily Transporters
Cation Diffusion Facilitator (CDF) Family
Amino Acid Secondary Transporters
Antiporters
Name
ClC : H+/Cl- Exchange Transporter
GlpT : Glycerol-3-Phosphate Transporter
LacY : Lactose Permease Transporter
EmrD : Multidrug Transporter
YiiP : Zinc Transporter
GltPh : Glutamate Transporter
LeuTAa : Leucine transporter
NhaA : Na+/H+ antiporter
AcrB : bacterial multi-drug efflux transporter
EmrE : bacterial multi-drug efflux transporter
Species
Salmonella typhimurium
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Pyrococcus horikoshii
Aquifex aeolicus
Escherichia coli
Resolution
3.0Å
3.5Å
3.5Å
3.8Å
3.3Å
3.6Å
3.5Å
3.8Å
3.5Å
1.65Å
3.45Å
Reference(s)
MacKinnon R. et al. (2002).Nature
MacKinnon R. et al. (2002).Nature
Yamaguchi et al. (2002).Nature
Chen G. et al. (2007).PNAS
Wang DN. et al. (2003).Science
Iwata S. et al. (2003).Science
Chang G. et al. (2006).Science
Fu D. et al. (2007).Science
Gouaux E. et al. (2004).Nature
Gouaux E. et al. (2005).Nature
Michel H et al. (2005).Nature
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Fig. 1 Schematic drawing of a possible conformational change upon substrate transport.
The left panel shows the outward-facing state. The cysteine residue introduced at the
position of glycine 62 was labeled by OGM, but cysteine residues introduced at the
position of proline 79 was not labeled. The right panel shows the substrate-occluded state.
The labeling reaction at glycine 62 was inhibited, while the labeling reaction at proline 79
was stimulated by aspartate.
A B
C D
E F
G H
Fig. 2. Overall structures and possible substrate transport mechanisms of secondary
transporters. Ribbon representations of secondary transporters viewed parallel to the membrane
(A, LacY; C, Gltph; E, LueTAa; G, NhaA). Putative substrate transport mechanisms were shown
(B, LacY; D, Gltph; F, LueTAa; H, NhaA). All figures were adapted from references; LacY, ; GltPh,
; LueTAa, G; NhaA, .
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SUMMARY (JAPANESE) 
 
 
 
Structure and transport mechanism of AspT, aspartate:alanine antiporter of lactic acid 
bacterium Tetragenococcus halophilus. 
 
(醤油乳酸菌 Tetragenococcus halophilus アスパラギン酸： 
アラニン交換輸送体 (AspT) の構造と輸送機構に関する研究) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEI NANATANI 
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第一章 序論 
 
人類は有史以前から微生物を巧みに利用して、ビール（酒類）、味噌、醤油等を製造
してきた。現代では、これら醸造製品の他に様々な有用物質（アミノ酸、抗生物質、光
学活性化合物、酵素、ワクチンなど）が、微生物を利用して生産されており微生物は産
業的に不可欠なものとなっている。古くから発酵という形で微生物を物質生産に利用し
て来た日本では、1960 年代から 70 年代にかけて、世界に先駆けて数多くの有用な抗
生物質の発見、代謝調節と呼ばれる方法を駆使したアミノ酸の発酵生産と微生物利用技
術の開発が相次ぎ、この時代に世界をリードする微生物利用技術が確立された。 
しかしながら、近年、この分野へアメリカ、ドイツなどの先進国に加え、韓国、中国
などの比較的人件費の安価な国々が参入し、競争が激化している。このような世界的な
状況の中で、日本の微生物産業が世界の需要に応えるために、一層安価な製造法が要望
され、研究開発が進められているが、従来からの有用微生物探索、新規代謝経路の探索、
遺伝子工学的手法を用いた機能強化などの方策では根本的な解決には至っていないの
が現状である。そのため、これまでにない全く新しい視点からの解決策が望まれている。 
そこで、本博士論文研究では代謝反応の初期段階にあたる基質の菌体内への輸送、最
終段階にあたる生産物の菌体外への輸送というプロセスに着目した。微生物において、
物質の輸送はホメオスタシスを維持するために厳密にコントロールされており、不要な
物質の取り込みや必要な物質の排出をするようなことはない。すなわち、有用物質の生
産量を改善するためには、物質輸送を人為的にコントロールする必要がある。 
これまでに、阿部らは醤油乳酸菌 Tetragenococcus halophilus と alanine 生産菌 
Comamonas testosteroni において、aspartate を基質とし alanine を生産するシステムが、
基質として aspartate を菌体内に取り込み、菌体内での aspartate の脱炭酸反応の生成物
である alanine を菌体外に排出する反応であることを見い出した（Abe et al. 1996. J. 
Biol. Chem.）。さらに、この反応は、aspartate--decarboxylase（AspD）と aspartate: alanine 
antiporter（AspT）の２つの要素のみによって構成されていることを明らかにした（Abe 
et al. 2002 J. Bacteriol.）。この aspartate → alanine 変換系は、(i) 反応を構成する要素が
尐なく、反応が脱炭酸反応と基質：生成物の交換輸送の 2 段階で完結する。(ii) 輸送
の過程でエネルギーを消費することなく、逆にエネルギー生成に寄与している。(iii) 反
応が、他の代謝反応と隔離されている。(iv) 反応が不可逆的である。 などの特徴から、
前述の物質の輸送をコントロールすることによる有用物質生産の効率化のモデルと成
りうると考えた。そこで、本博士論文研究では、産業微生物における効率的な物質輸送
を実現するため、その基盤研究として、生化学的な手法により AspT の構造と機能を
解析し、基質輸送メカニズムの解明に挑んだ。 
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第二章 Fusion 法による AspT の二次構造解析 
 
はじめに AspT の推定アミノ酸配列から膜貫通  -ヘリックス (Trans membrane 
-helix, TM) の位置を予測するプログラム (TMpred,  TMHMM, SOSui) を用いて、
AspT の TM の位置を予測した。その結果 9 〜 12 個の TM の存在が示唆され、こ
れらの結果を比較すると、中程度の疎水性を示す領域の予測に違いが生じていた。中程
度の疎水度を持つ領域は、膜貫通 - ヘリックスを形成している場合には基質透過経
路を構成している可能性があるが、膜外に存在する場合には膜に近接して存在する可能
性が示唆され、AspT の構造において重要な領域であると考えられた。そこで、本研究
では、始めにレポータータンパク質 (Alkaline phosphatase [PhoA]、 -lactamase [BlaM]) 
との融合タンパク質を用いた解析により AspT の細胞膜上での二次構造の解析を行っ
た。 
AspT の C 末端デリーションシリーズの C 末端及び N 末端に、 PhoA, BlaM をレポ−
タータンパク質として融合させたタンパク質を大腸菌を宿主として発現させた。PhoA fusion 法
では、融合タンパク質を発現させた菌株の PhoA 活性を膜不透過性の基質 pNPP を用いて
測定することにより、PhoA が cytoplasm 側で発現しているのか、periplasm 側で発現して
いるのかを推定した。BlaM fusion 法では、融合タンパク質を発現させた菌株を 50 - 800 
g/ml -lactam 系抗生物質 (carbenicilline) を含んだ培地で培養し、最小生育阻止濃度 
(MIC) を測定することにより、BlaM の細胞膜上での位置を推定した。また、N 末端の
位置を決定するため、BlaM の C 末端側に AspT の全長と AspT の N 末端側半分を
融合させたタンパク質を発現させ解析した。 
PhoA fusion 法、BlaM fusion 法による解析の結果、AspT は 8 本の TM をもち、N-, C - 
末端は periplasm 側に位置し、TM 5 - TM 6 間には大きな親水性 cytoplasmic loop の存在
が推定され、これまでに報告されている輸送体にはない特有の構造を持つことが示唆された 
(Fig. 1)。しかし、PhoA fusion 法による解析結果と BlaM fusion 法の解析結果では、TM 6 - 
TM 7 間の推定構造に相違があり、さらに詳細な解析が必要となった。 
 
 
第三章 Cysteine-scanning 法による AspT の二次構造解析 
 
3-1 Cysteine-scanning 法による解析 
 
Cysteine-scanning 法は部位特異的変異導入と部位特異的化学修飾を融合した手法で
あり、親水的環境にある cysteine 残基のみが SH 基修飾試薬と効率的に反応する（細
胞膜内等の疎水的環境下では cysteine 残基の pKa は高く極めて反応性に乏しい）こ
とを利用した構造と機能の解析手法である。種々の膜不透過性 SH 基修飾試薬や、膜
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透過性 SH 基修飾試薬を組み合わせて用いることで、二次構造 (topology) の解析、膜
貫通ヘリックスからなり親水領域に面する基質透過経路 (translocation pathway) 等の解
析が可能となる。 
AspT の二次構造を Cysteine-scanning 法によって解析するため、histidine - tag を導入
し、3 つの内在性 cysteine 残基を全て alanine に置換した変異体 cysless-AspT-(His)6 
(以下 cysteine-less 体) を作製し、この変異体が輸送活性を保持していることを確認し
た。さらに、この cysteine-less 体を parent とし、任意のアミノ酸残基を 1 残基ずつ  
cysteine 残基に置換した single cysteine AspT-(His)6 (以下 single cysteine 置換体) を作
製した。大腸菌を用いてこれらの変異体を発現させ、膜不透過性蛍光 SH 基修飾試薬 
Oregon Green 488 maleimide (OGM) 及び、膜不透過性 SH 基修飾試薬 
[2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET) を作用させる
ことで、導入した cysteine 残基の細胞膜における位置を推定した (Fig. 2)。二次構造の
解析には基質輸送に必要な構造を確実に維持している変異体として cysteine-less 体の
比活性を 100% としたときの相対比活性が 30% 以上の変異体を用いた。各変異体の
ラベルパターンにより、 Ala3, Thr59, Lue151, Ser156, Pro160, Ser386, Ser448 及び Ser543 の残基
は periplasm 側に露出している事が示された (Fig. 3)。また、Ser33, Ala90, Met182, Met186, 
Leu
190
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194
, Ser
291
, Ser
356
, Tyr
408
, His
412
, Ser
421
, Thr
473
, Met
480
, Ser
486
 及び Ser510の残基は 
cytoplasm 側に露出している事が示された (Fig. 3)。以上の結果から、 AspT は 10 本
の膜貫通  -ヘリックス (TM) を有すること、TM 5 – TM 6 間に約 180 アミノ酸
から成る親水性の loop 領域 (LHC [large hydrophilic cytoplasmic] loop ) を有すること、 
N-, C- 末端は periplasm 側に位置していることが明らかになり、AspT が他に類を見な
いユニークな構造を持つことが分かった (Fig. 4)。 
 
3-2 LHC [large hydrophilic cytoplasmic] loop の構造解析 
 
二次構造解析によって得られた AspT の構造において最も特徴的な構造は、TM 5 - 
TM 6 間に存在する約 180 アミノ酸残基からなる親水性のループ領域 (LHC [large 
hydrophilic cytoplasmic] loop) である (Fig. 4)。現在までに 60 種類あまりの細菌類か
ら約 90 の AspT オルソログが見出されているが、これらのトランスポーターの多くが
中央に LHC loop 構造を持つことが、推定アミノ酸配列からの二次構造予測により示唆
されており、Aspartate:Alanine Exchanger  (AAE) ファミリーに属するトランスポー
ターの特徴的な構造ということができる。 
そこで、LHC loop の構造を明らかにするため loop 領域の部分発現および精
製 (Fig. 5A) を行い、 circular dichroism により二次構造を解析した (Fig. 5B)。その
結果、LHC loop はランダムな構造ではなく、- へリックスと - シートを含んだ高
次構造を形成していることが示唆された。 
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さらに、 詳細な構造情報を得るため北里大学薬学部梅山英明教授らのグループの開発
したタンパク質立体構造予測プログラム Full Automatic Modeling System (FAMS) 
により、 LHC  loop の三次元構造をモデリングした。結果を Fig. 6 A, B に示した。
モデリング構造より LHC loop 内には、2 つの alpha-beta complex structure (Fig. 6A, 
Domain 1, Val208–Phe277; Fig. 6B, Domain 2, Thr283–Gln352) が存在することが分かっ
た。特に、LHC loop の前半部分 Domain 1 は、アミノ酸配列から TrkA_C ドメイン
と推定された領域であるが、後半部分はアミノ酸配列からは TrkA_C ドメインとは推
定されなかったのにも関わらず、構造的には類似の構造を保持していた (Fig. 6C)。 
 
 
第四章 AspT の基質輸送メカニズムの解析 
 
4-1 AspT の多量体構造の解析 
 
AspT の多量体構造を決定することは、AspT による基質輸送のメカニズムを解明す
る上で重要な事項の一つである。そこで、生化学的な手法により AspT の多量体構造
について解析した。 
多量体構造の解析に先立ち、AspT を n-dodecyl--maltopyranoside (DDM) を用いて可
溶化・精製する系を構築した。本研究では、これまでに界面活性剤として 
1-O-n-Octyl--glicopyranoside (OG) を膜タンパク質の可溶化に用いてきたが、OG は 限
界ミセル濃度 (CMC) が極端に高いため、可溶化状態を長時間安定的に保つためには
リン脂質の添加が必要であった。しかし、このリン脂質は分子間架橋反応や結晶作製な
どの生化学的な実験を行う際には妨害物質となる場合がある。そこで、OG よりも 
CMC が低く、リン脂質の添加なしで安定的に可溶化状態が維持できる DDM による
可溶化と Ni-NTA カラムを用いた精製法を確立した (Fig. 7A)。精製した DDM 可溶
化 AspT をプロテオリポソームに再構成し、aspartate：aspartate 自己交換反応、aspartate：
alanine 交換反応を測定し、これらの反応が維持されていることを確認した。 
続いて、size exclution - HPLC を用いて DDM 可溶化 AspT の分子量を推定した。そ
の結果、DDM 可溶化 AspT の推定分子量は 204 kDa であった (Fig. 7B)。この結果は、
AspT に DDM が結合した状態の見かけの分子量を示しているため、AspT が何量体を
形成しているのかを断定することはできないが、AspT のアミノ酸配列より推定される
分子量 57 kDa よりはるかに大きいな分子量であることから、AspT が尐なくとも多量
体を形成していることは推察できた。 
さらに、精製した DDM 可溶化 AspT に、分子間架橋剤としてグルタルアルデヒド 
(終濃度 0.05 - 0.5 mM) を添加し、25℃で 30 分間反応させた。反応後のサンプルを 
SDS-PAGE に供し、銀染色により架橋形成による泳動度の変化を観察した (Fig. 8)。コ
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ントロールとして、SDS により変性後、グルタルアルデヒド架橋反応を行ったサンプ
ルも同時に泳動した。その結果、SDS による変性後の AspT では架橋反応が起こらな
かったのに対し、DDM 可溶化 AspT では架橋反応が起こり二量体、三量体が検出され
た。以上の結果から、DDM 可溶化 AspT が多量体を形成していることが示唆された。 
 
4-2  基質透過経路の解析 
 
AspT の 10 本の膜貫通 - へリックスのうち 3 番目の膜貫通 - ヘリックス 
(TM 3) には、疎水性へリックス中に荷電性残基である arginine が存在し、さらに AAE 
ファミリーに属するトランスポーターで保存されている残基が多数存在する (Fig. 9) 
などの点から、基質透過経路を形成するヘリックスの一つであると推定し、TM 3 に位
置するアミノ酸残基を １ 残基ずつ cysteine に置換した single cysteine 変異体を
作製し、OGM を SH 基修飾試薬として用いて Cysteine-scanning 法により解析した。 
はじめに、作製した各 single cysteine 置換体をプロテオリポソームに再構成し、
aspartate の初期取り込み速度を測定した (Fig. 10)。その結果、Tyr75、Ser84 を cysteine に
置換した変異体で優位に活性が失われており、これらの残基が AspT による aspartate 
の輸送に関与している可能性が示唆された。 
続いて、OGM による修飾実験を行った。各変異体を発現させた大腸菌から調製した 
membrane ghost を aspartate を含んだ緩衝液と含まない緩衝液、それぞれに懸濁し、
OGM 修飾反応を行った。導入した cysteine 残基が cytoplasm 側、periplasm 側のどち
らかに露出している場合、OGM による修飾反応が起き、OGM の蛍光が検出される。
結果を Fig. 11 に示した。TM 3 には、aspartate 存在時、非存在時どちらにおいてもラ
ベルされない領域が存在し、この領域が TM 3 の core 領域であることを明らかにした。
さらに、この領域を挟んで periplasm 側と cytoplasm 側それぞれに aspartate の存在下、
非存在下で修飾パターンの変化する残基が存在していた。G62C は、aspartate 非存在下
では OGM による修飾を受けるが、aspartate の存在下では修飾を受けなかった。一方、
P79C は aspartate 非存在下では修飾されなかったが、存在下では修飾された。つまり、
periplasm 側の Water - Filled Pore に位置する G62C は aspartate 非存在下では OGM 
による修飾を受けるが存在下では受けず、逆に cytoplasm 側の Water Filled Pore に位置
する P79C は aspartate 存在下のみで修飾された。以上の結果は、AspT が基質である
aspartate との結合により構造変化を起こし、periplasm 側に開口していたものが 
cytoplasm 側に開口した構造に変化したことを意味しており、AspT が基質との結合に
より構造変化を伴う alternating access mechanism によって基質を輸送していることを
示唆している (Fig. 12)。 
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第五章 総合考察 
 
5-1 AspT の二次構造解析 
 
はじめに、 PhoA-, BlaM-fusion 法、Cysteine-scanning 法を用いた解析から、 AspT が
非常にユニークな二次構造を持つことを明らかにした (Fig. 1, 4)。特に、TM 5 – TM 6 間
の約 180 アミノ酸残基からなる親水性の巨大なループ構造 (LHC loop) は、AAE ファ
ミリーに共通した構造でありながら、これまでに解析されたトランスポーターにはない、
機能未知の特徴的な構造である。アミノ酸配列からドメイン構造を予測するプログラム 
InterProScan Sequence Search により、LHC loop には、TrkA_C ドメインと呼ばれる
ドメイン構造が １ つあることが予測された。TrkA_C ドメインは、K+ の輸送制御を
担うタンパク質 TrkA において最初に見い出されたドメイン構造であるが、現在までの
ところ機能は明らかにされておらず、何らかのリガンドが結合し輸送制御に関わってい
るのではないかと推定されている。これまでに報告されている二次性輸送体において、
このように輸送制御に関わると推定されるドメイン構造を同一タンパク質分子内に持
った輸送体の報告例はなく、AspT における LHC loop の構造と機能は非常に興味深い。
そこで、LHC loop 領域のみを大腸菌を用いて発現・精製し、CD スペクトルを測定し
た (Fig. 5A, B)。この結果より LHC loop は、 -へリックスと -シートを含んだ高次
構造を形成していることを明らかにした。さらに、FAMS による立体構造モデリングか
ら、LHC loop には alpha-beta complex structure が繰り返し存在することが推定された 
(Fig. 6)。LHC loop Domain 1 と Domain 2 は、アミノ酸配列の相同性は低いにも関わ
らず、立体構造モデリングの結果においては非常に類似した構造を保持している点が興
味深い。モデリング構造から -へリックスと -シート間のポケットにリガンド分子
の入り込める隙間があることがわかり、LHC loop の機能的な推測を支持する結果が得
られたが、同領域の機能についてさらに詳細な議論を進めるためには、更なる機能面お
よび構造面からの解析が必要である。 
 
5-2 AspT の基質透過経路の解析 
 
第四章では、AspT がどのようなメカニズムで基質を輸送しているのか明らかにする
ため、荷電性残基である arginine が存在し、さらに AAE ファミリーに属するトラン
スポーターで保存されているアミノ酸残基が多数存在する TM 3 (Fig. 9) に着目し、 
Cysteine-scanning 法による解析を行った。その結果、cysteine 残基への置換によって優
位に活性を失っているアミノ酸残基 (Tyr75, Ser84) を見出し、これらの残基が基質輸送に
関与している可能性が示唆された (Fig. 10)。また、OGM による修飾実験により Ile64
から Tyr75に位置するアミノ酸残基は OGM による修飾を受けない core region を形成
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していることを示した (Fig. 11)。さらに、この core region を挟んで両側に aspartate 存
在下と非存在下で OGM による修飾効率が変化するアミノ酸残基を見出した。この結
果は、AspT が基質である aspartate との結合により構造変化を起こし、periplasm 側に
開口していたものが cytoplasm 側に開口した構造に変化したことを示唆しており、
AspT が基質との結合により構造変化を伴う alternating access mechanism (Fig. 12) によ
って基質を輸送していることを示唆している。これまでの生化学的な実験結果および 
in vivo での実験結果より AspT は、Fig. 12 に示したような ４ つのコンフォーメーシ
ョン変化を伴ったメカニズムによって基質を輸送していると推定され、本研究ではこれ
らのコンフォメーションの中で (A) と (D) の ２ つの構造の存在を証明することが
できた。 
 
5-3 将来展望 
 
長年の生化学的な研究と近年のゲノム解析の進展により、微生物においても多岐にわ
たるトランスポーターファミリーが存在することが明らかとなってきた。これらの輸送
体は、微生物にとって生理学的に重要な役割を果たすだけでなく、原料（前駆体）を菌
体内への取り込み、製品（代謝産物）を菌体外への排出する役割を担っていることから、
アミノ酸をはじめ発酵法によって製造されている物質のほとんどは、その製造過程でト
ランスポーターを介して細胞膜を透過していることになり、産業的にも非常に重要であ
ると考えられる。1957年にグルタミン酸生産菌として、Corynebacterium glutamicum が
発見されて以来、現在では年間 100 万トンが発酵法により製造されているグルタミン
酸に関しても、細胞内での代謝反応により生合成された後、どのような仕組みで培地中
に排出されるのかは長らく不明であった。しかし、近年、この培地中への排出にグルタ
ミン酸 exporter が関与していることが明らかにされ (Nakamura J., et al ,(2007）
Appl. Environ. Microbiol.)、微生物産業における膜輸送体の重要性の認識が高まりつつ
ある。本研究により、AspT の特徴的な構造として、LHC loop 内に輸送制御に関わる
と推定されるドメイン構造 (TrkA_C ドメイン) を見出すことができた。本ドメインは、
構造的、機能的に興味深いだけではなく、物質輸送を制御するという観点から将来的に
産業応用に繋がる非常に重要な領域であると考えている。 
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要約 
I. AspT の二次構造解析  
PhoA, BlaM-fusion 法、Cysteine-scanning 法を用いた解析から、 N-, C- 末端を periplasm 
側に持つ。10 本の膜貫通 - へリックスを持つ。TM 5 – TM 6 間に約 180 アミノ酸
残基からなる親水性の巨大なループ構造 (LHC loop) を有する。 等の特徴的な二次構
造を持つことを明らかにした。 
 
II. 親水性ループ領域の構造解析  
LHC loop 領域の CD スペクトルおよび FAMS による立体構造モデリングから、LHC 
loop には alpha-beta complex structure が繰り返し存在することを明らかにした。  
 
III.  多量体構造の解析 
AspT を界面活性剤に DDM を用いて可溶化、Ni-NTA カラムによる精製、再構成する
系を構築した。さらに、size exclusion – HPLC 、グルタルアルデヒドを用いた架橋実験
により AspT が多量体を形成していることを明らかにした。  
 
IV.  Cysteine-scanning 法による基質透過経路の解析 
TM 3 を Cysteine-scanning 法により解析し、aspartate の輸送に関与すると推定される
アミノ酸残基を同定した。 さらに、TM 3 の core region を同定し、その前後に aspartate 
との結合によりラベル効率の変化する残基を見出した。 以上の結果から、AspT が 
alternating access mechanism タイプの基質輸送メカニズムを有することが推定された。  
 
 
Fig. 1 Topological model
of AspT, based on the
results of PhoA fusions
(A) and BlaM fusions (B).
(A) PhoA fus ion s i t e s a re
indicated by black circles. The
numbers in parentheses indicate
unit of PhoA activity (units).
(B) BlaM fus ion s i t e s a re
indicated by black circles. The
n um ber s i n p a ren t hes es
correspond to the MIC (µg/ml)
of β-lactam. Positively charged
residues and negatively charged
residues are indicated by open
c i r c l e s and open b ox es ,
respectively.
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Fig. 2 Orientation of TM3. (A) After SDS-PAGE of purified proteins, a fluorescence profile was recorded
(right panels) before the same gel was stained with Coomassie Brilliant Blue (CBB) to reveal total protein (left panels).
Lanes 1, OGM added to intact cells; lanes 2, OGM added to membrane ghosts prepared after pretreatment of cells
with MTSET; lanes 3, OGM added to membrane ghosts prepared without pretreatment with MTSET. (B) Deduced
orientations of TM3. The black circle represents the cytoplasmic target, A90C; the gray circle represents the
periplasmic target, T59C.
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Fig. 6 Modeling of the large hydrophilic loop region of AspT. (A) Superposition of the model
of the AspT loop domain 1 (Valine208-Phenylalanine277, green) and the structure of the MthK TrkA_C
domain (Methionine264-Isoleucine334, yellow). The root mean square deviation (RMSD) of these structures
is 0.38Å. (B) Superposition of the model of the AspT loop domain 2 (Threonine283-Glutamine352, green)
and the structure of the protein PH0236 TrkA_C domain (Isoleucine122-Isoleucine192, yellow). The RMSD
of these structures is 0.54Å. (C) Superposition of the model of the AspT loop domain 1 (green) and the
model of the AspT loop domain 2 (cyan). The structures of domain 1 and domain 2 were superposed by
means of the Combinatorial Extension (CE) algorithm (38). The RMSD of these structures is 1.29Å.
A B
34.6
20.0
27.0
66.4
14.3
-15
-10
-5
0
5
190 200 210 220 230 240 250
Wavelength (nm)
El
lip
tic
ity
x
10
3
(d
eg
cm
2
dm
ol
-1
)
(kDa)
Fig. 5 SDS-PAGE profile and circular dichroism spectrum of the AspT large
hydrophilic loop region. (A) SDS-PAGE profile obtained after purification of the AspT large
hydrophilic loop region (Arginine 178-Asparagine 361). The right lane contained 2 µg of the purified loop
region. Standards of the indicated masses are in the left lane. (B) Circular dichroism spectrum; the spectrum
represents the average of 10 scans corrected by using a reference solution without the protein.
Fig. 7 Purification of AspT and analytical size exclusion HPLC of the purified AspT. A, SDS-
PAGE analysis of purified AspT. B, Log molecular weight standards vs retention (ml). The AspT-DDM
complex has an apparent molecular mass of 204 kDa according to a calibration using following protein
standards as indicated: OA, ovalbumin (43 kDa); CA, canalbumin (75 kDa); AL, aldolase (158 kDa);
FR, Ferritin (440 kDa).
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Fig. 8 Glutaraldehyde cross-linking of AspT. Image of Silver-stained SDS-PAGE gel of AspT after
glutaraldehyde (GA, 0.05 - 0.5mM) cross-linking in 0.02% DDM or 0.5%SDS.
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Fig. 9. Sequence alignment of putative TM 3 of AspT and its orthologues. The sequence
alignment shows a consensus of 4 bacterial AspT orthorogues, including AspT. The sequences were
aligned using the Clustal W algorithm. * indicates fully conserved residues,・indicates quite highly
conserved residues.
Fig. 10 Aspartate transport by TM 3 single-cysteine mutants. AspT function was evaluated for a single-
cysteine panel spanning TM 3 (T59C-F88C). Initial rates of [3H]aspartate transport, normalized for levels of AspT
expression, are given relative to that of the cysteine-less parental protein, whose activity was 4.24 nmol/min/mg of
protein (horizontal line).
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Fig. 12 Proposed substrate transport mechanism of AspT.
Fig. 11 OGM binding to single-cysteine variants of TM 3. The hydrophobic core of TM 3 was defined
experimentally by OGM labeling of the indicated single-cysteine variants spanning the whole of the transmembrane
segment. Membrane ghosts of each variant were exposed to OGM in the presence or absence of aspartate, prior to protein
solubilization, purification and analysis using SDS-PAGE. A single gel containing all samples was used to record the
fluorescence signal (bottom panel) before staining with Coomassie Blue to visualize protein (top panel).
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